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Summary 
 
Astrocytes are organized in what can be regarded as parallel networks to local neuronal 
networks. On the cellular level astrocytes immediately react to stimulated neuronal activity by 
transient increases in intracellular calcium concentration ([Ca2+]i) which results in vitro in a 
vesicular release of so-called gliotransmitters such as ATP, D-serine and glutamate. In turn these 
gliotransmitters directly modulate synaptic transmission. Those synapses are regarded as tri-
partite connections composed of the pre- and post-synapse enveloped by astrocyte processes. 
Several mouse models suggested astrocytes as key entities to tune synaptic transmission to 
vigilance states of synchronized neuronal activity oscillations. However, due to conflicting 
findings it is still under debate whether gliotransmission takes place under physiological 
conditions and, in particular, whether and how the activity of a single astrocyte or the general 
astrocyte population is an indicator for altered coordinated activity of a neural network. 
 In the presented study the bidirectional communication of astrocytes and neurons was 
investigated. First, by a glia-neuron tracing approach in vivo and second by the simultaneous 
recording of neuronal and astrocytic activity during pharmacologically-induced oscillatory 
activity of cultured hippocampal slices. The tracing approach demonstrated in multiple 
independent experiments, that the rAAV-delivered retrograde tetanus toxin heavy chain tracer 
(eGFP-TTC) in hippocampal neurons is transferred to retrogradely connected neurons but is not 
translocated to, or between astrocytes. This excludes the existence of the neuron-like 
presynaptic target structures in astrocytes, exploited by eGFP-TTC. Likewise, eGFP-TTC is not 
transferred from astrocytes to neurons. Thus, the eGFP-TTC experiments cannot be used for 
tracing of neurons in putative networks build of tripartite synapses and moreover do not 
support the gliotransmission hypothesis. For the population analysis during neuronal 
oscillations, astrocyte [Ca2+]i and neuronal [Ca
2+]i transients were recorded simultaneously by 
neuron- and astroglia-transduced Ca2+ indicators jRGeco and GCaMP6f, respectively. In both cell 
types the frequency and the kinetics of [Ca2+]i transient were not affected by the 
pharmacologically induced oscillations. Temporal cross-correlation analysis of the activity failed 
to identify any correlations in astrocytes and neuronal [Ca2+]i signals and could not identify any 
preferred [Ca2+]i transient sequence patterns. From these observations it can be concluded, that 
in the pharmacologically induced oscillation model either the [Ca2+]i transients in both cell 
populations are independent from the conditions and from each other, or that the applied virus 
delivered activity indicators combined with epifluorescence imaging are insufficient to allow 
detection of subtle correlations in these cells.  
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Zusammenfassung 
 
Astrozyten sind in parallelen Netzwerken zu lokalen neuronalen Netzwerken organisiert und es 
wurde wiederholt nachgewiesen, dass einzelne Astrozyten in vitro direkt auf stimulierte 
neuronale Aktivität mit transienten Anstiegen der intrazellulären Kalziumkonzentration [Ca2+]i 
reagieren. Diese Transienten führen zu einer vesikulären Freisetzung von Transmittern wie z.Bsp. 
ATP, D-Serin oder auch Glutamat durch die Astrozyten, die sog. Gliotransmission. Diese 
Transmitter beeinflussen direkt die neuronale synaptische Signalübertragung, weshalb man seit 
einigen Jahren bestimmte Synapsen als drei-, statt zwei-teilige Struktur versteht. Der dritte Teil 
wird hierbei von Astrozytenausläufern gebildet und umhüllt die Prä- und Postsynapse. In vivo 
Mausmodelle suggerieren, dass die Astozytenaktivität synchronisierte Oszillationen in der 
neuronalen Aktivität wesentlich beeinflussen. Es ist jedoch nach wie vor ist umstritten, ob 
Gliotransmission unter physiologischen Bedingungen stattfindet und insbesondere, ob und wie 
Veränderungen in der Aktivität von neuronalen Netzwerken durch die Aktivität einzelner 
Astrozyten oder der Gesamtheit der Astrozytenpopulation gemessen werden kann. 
 In der vorliegenden Studie wurde die bidirektionale Kommunikation zwischen 
Astrozyten und Neuronen im Detail zum einen mit einem Glia-Neuron-Tracing-Ansatz in vivo und 
zum anderen mit simultanen Aktivitätsmessungen von Neuronen und Astrozyten während 
pharmakologisch induzierter neuronaler Oszillationen in Gehirnschnittkulturen, untersucht. Im 
Tracing-Ansatz konnte eindeutig gezeigt werden, dass der von rAAV gelieferte retrograde Tracer 
(eGFP-TTC), welcher auf Tetanustoxin basiert, von hippocampalen Neuronen retrograd auf 
synaptisch verbundene Neurone übertragen wird, dabei jedoch nicht auf Astrozyten. Daher kann 
geschlussfolgert werden, dass die von eGFP-TTC benötigten Neuronen-ähnlichen 
präsynaptischen Strukturen nicht bei Astrozyten existieren. Weiterhin bedeutet das Ergebnis, 
dass das präsentierte Tracing-system nicht für die Kartierung von neuronalen Netzwerken, 
welche sich drei-teilige Synapsen mit Astrozyten teilen, genutzt werden kann. Für die 
Aktivitätsmessungen wurden gleichzeitig [Ca2+]i -Transienten von Astrozyten und Neuronen mit 
den zellspezifisch transduzierten Ca2+-Indikatoren jRGeco bzw. GcaMP6f gemessen. In beiden 
Zelltypen wurden die Frequenz und die Kinetik der [Ca2+]i transienten durch Gamma-
Oszillationen nicht beeinflusst. Auch Kreuzkorrelationsanalysen von Astrozyten- und 
Neuronenaktivität konnten keine zeitlichen Zusammenhänge oder bevorzugte [Ca2+]i -
Sequenzmuster identifizieren. Diese Ergebnisse zeigen, dass das in dem pharmakologisch 
induzierten Oszillationsmodel entweder die Astrozyten- oder die Neuronenaktivität unabhängig 
voneinander und von den Oszillation sind, oder dass die angewandten Methoden, wie z.B. die 
viral transduzierten Kalziumindikatoren oder die Verwendung von Epifloureszenzmikroskopie, 
nicht ausreichen um subtile Muster in der Aktivität dieser Zellen zu detektieren.   
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Abbreviations 
 
[Ca2+]i Intracellular calcium concentration 
A AAV Adeno-associated virus 
 
AChR Acetylcholine receptors 
 
ACSF Artificial cerebrospinal fluid 
AMPAR α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
 ATP Adenosine triphosphate 
 
AP Anterior-posterior 
B bp Base pair 
 
BSA Bovine serum albumin 
C cAMP Cyclic adenosine monophosphate 
 
CA Cornu ammonis 
 
CCH Carbachol 
 
CCH-GM Carbachol induced gamma oscillations 
 
cm Centimetre 
 
contra Contralateral 
D DAPI 4’,6-Diamidino-2-phenylindole 
 
DF Dorsal fornix 
 
DG Dentate gyrus 
 
DIO Double inverted orientation 
 
DMEM Dulbecco’s modified eagle medium 
 
DNA Deoxyribonucleic acid 
 
dNTP Deoxyribose nucleoside triphosphate 
 
DV Dorso-ventral 
E EC Entorhinal cortex 
 
EEG Electroencephalography 
 
eGFP Enhanced green fluorescent protein 
F FCS Fetal calf serum 
 
FISH Fluorescence in situ hybridisation 
G GABAAR γ-aminobutyric acid receptor type A 
 
GBZ Gabazine 
GFAP Glial fibrillary acidic protein 
 
GFP Green fluorescent protein 
 
gr Granular layer 
H HEK293 Human embryonic kidney 293 cell line 
I IP3 Inositol-3-phosphate 
 
i.p. Intraperitoneal 
 
IF Immunofluorescence 
 
ipsi Ipsilateral 
K KO Knock out 
 
KusO Kusabira orange 
 
LB Lysogeny broth medium 
L LD  Lateral dorsal nucleus of the thalamus    
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LFP Local field potential 
 
LS Lateral septal nucleus of the thalamus 
LTP Long term potentiation 
M mAChR Metabotropic acetylcholine receptor 
 
MCS Multiple cloning site 
 
MEM Minimum essential medium 
mGluRs Metabotropic glutamate receptors 
 
MPI Max Planck Institute 
N NeuN Neuronal nuclear antigen 
 
NGS Normal goat serum 
NMDAR N-methyl-D-aspartate receptor 
O or Stratum oriens 
P PBS Phosphate buffered saline 
 
PCR Polymerase chain reaction 
 
PFA Paraform aldehyde 
 
Pks Peaks 
 
pM Picomolar 
 
po Polymorph layer 
 
py Pyramidal layer 
R ra  Stratum radiatum 
 
rAAV Recombinant adeno-associated virus 
 
RNA Ribonucleic acid 
 
ROI Region of interest 
 
rpm Rounds per minute 
 
RSP Restrosplenial cortex 
 
RT Room temperature 
S s Second 
 
SD Standard deviation 
 
SEM Standard error of the mean 
 
Syn Synapsin promoter 
T TAE Tris-Acid-EDTA buffer 
 
TB Terrific broth medium 
 
TeNT Tetanus neuro toxin 
 
TTC Tetanus toxin c-fragment 
 
TTX  Tetrodotoxin 
W WT Wild type 
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1. Introduction 
 
Since the discovery of astrocytes as cellular structures in the late 19th century by Michael 
Lenhossek, scientists speculated and discussed their functional importance (Kettenmann and 
Ransom, 2005). Astrocytes are electrically silent partners of neurons (Petersen et al., 2005). 
Today it is well established, that astrocytes, which surround neurons, are critical for numerous 
tasks, such as establishing the blood brain barrier (Bundgaard and Abbott, 2008) and the 
clearance of extracellular potassium and neurotransmitters released from neurons (Djukic et al., 
2007). More recently it has been proposed that astrocytes also maintain energy homeostasis by 
shuttling metabolites (Allaman et al., 2011), and by establishing neuro-vascular coupling, to 
adjust blood flow depending on neuronal activity (Iadecola and Nedergaard, 2007; Nizar et al., 
2013). A number of studies also provided evidence that astrocytes are involved in pathological 
processes for example in Alzheimer’s disease (von Bernhardi, 2007; Taylor et al., 2007). 
 Thus, there is a plethora of functions identified and putative pathways to regulate these, 
drafting a very complex image of the astrocytes’ physiological performance. It is challenging to 
dissect how astrocytes orchestrate their versatile functions and while more and more details are 
explored on how they achieve these tasks, some results are contradicting and require further 
and deeper investigation.   
 Since astrocytes and neurons coexist in all brain areas, it is crucial to understand if and 
how they cooperate and how one influences the others performance. This aspect has been 
neglected in the past and only recently the contribution of astrocytes to physiological processes 
in the brain have been started to be elucidated.  
1.1 The astrocyte network 
Named after their shape, astrocytes in general have small cell bodies (10 – 20 µm) compared to 
their neighbouring neurons and have numerous so-called perisynaptic nano-processes spanning 
non-overlapping territories (Bushong et al., 2002; Jayant et al., 2017). Organized in these 
territories, astrocytes form a network, parallel to that of the neurons, by gap-junction coupling. 
Gap-junctions are formed by connexons, hetero-hexamers of the connexin (Cx) proteins. 
Astrocytes specifically express the connexin subtypes Cx43 and Cx30 (Giaume et al., 2010). These 
hexamers sit in the plasma membrane and bind connexons from adjacent astrocytes in order to 
INTRODUCTION 
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form gap-junctions (Theis et al., 2005). These aqueous channels are roughly 1.5 nm in diameter 
and are permeable for small molecules between 1 and 1.2 kDa (Bruzzone et al., 2003; Dermietzel 
et al., 1989). Therefore, gap-junction coupling facilitates extensive network communication by 
allowing direct exchange of ions and small molecules such as calcium ions (Ca2+), inositol-3-
phosphate (IP3), and cyclic adenosine monophosphate (cAMP) from one astrocyte to another. 
The formation of these networks is by no means global but is selective to subpopulations of 
astrocytes. One example are astrocytes of the olfactory bulb extra- and intraglomerular region. 
Infusing one astrocyte in the extraglomerular region with gap-junction permeable indicator dye 
labelled all surrounding astrocytes within the region of the glomerulus. The dye however, would 
not diffuse to the intraglomerular region but stop directly at the border of the next glomerulus 
(Bushong et al., 2002). Similar examples can be seen throughout the brain, especially in strictly 
compartmentalized regions such as the somatosensory cortex and the hippocampus (Dallérac et 
al., 2018). Interestingly, in the latter the coupling strength differs in between regions; CA1 
astrocytes show stronger coupling compared to their CA3 neighbours (D’Ambrosio et al., 1998). 
The selective gap-junction coupling of astrocytes is thought to be achieved by heterogeneous 
expression of the Cx proteins which is in turn depending on the tissue type as well as the 
developmental stage (Tsai et al., 2012). The exact functional relevance of intercellular coupling 
and its differential characteristics depending on regions is unknown. Compartmentalization, 
however, coincides with large functional neuronal territories (Medina et al., 1999) hinting 
towards an important role of these astrocyte networks in modulating and supporting neurons in 
their functions. Further, conditional knock-out (KO) animals for Cx30 and Cx43 showed impaired 
neuronal functions (Wallraff et al., 2006). While the electrophysiological properties of the Cx-
deficient astrocytes remained the same, the potassium buffering properties and the threshold 
for epileptiform activity in slices obtained from Cx30 and Cx40 deficient mice were lowered 
(Wallraff et al., 2006). Moreover, Chever et al. 2016 showed that a loss of Cx43 and Cx30 results 
in an increase of bursting incidences in disinhibited slice preparations, concluding that the 
astrocyte network is involved in coordination of neuronal activity (Chever et al., 2016). While it 
remains unclear how exactly astrocyte gap-junction coupling contributes to neuronal 
coordination, the anatomical features of compartmentalized astrocyte networks as well as 
functional consequences in Cx KO mouse lines implicate that astrocyte to astrocyte 
communication is vital also for neuronal networks (Pannasch and Rouach, 2013). In the past, 
studies focusing on astrocytes especially in vitro failed to take this important functional aspect 
into consideration, therefore omitting a prominent feature that most likely has an impact also on 
astrocyte to neuron communication.  
INTRODUCTION 
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1.2 The tripartite synapse 
It has been proposed that neurons not only sit embedded in the above described astrocyte 
network, but that astrocytes are an important and intimate partner in synaptic transmission. 
Due to their spongiform morphology a single astrocyte is potentially in contact with an 
estimated 100.000 synapses of about 4 – 8 different neurons (Bushong et al., 2002). Anatomical 
studies (Ventura and Harris, 1999) showed that astrocytes envelope synapses and recent 
functional assays showed that astrocytes can shape synapses by secreting signalling molecules 
(Di Castro et al., 2011; Henneberger et al., 2010; Jourdain et al., 2007; Miller et al., 2019; Pascual 
et al., 2005; Shigetomi et al., 2013). Therefore, the model of the tri-partite synapse was 
proposed adding to the pre- and the post synapse a third interaction partner; the astrocyte 
(Araque et al., 1999). 
 The details how astrocytes influence or even participate in neurotransmission are in the 
process of being elucidated and a number of possible mechanisms are being discussed. It is 
undisputed that astrocytes directly react to synaptic activity, which can be observed with 
fluorescent Ca2+ indicators (Tang et al., 2015; Verkhratsky and Parpura, 2013). Almost three 
decades ago in 1990 Cornell-Bell was able to show, that astrocytes exhibit intracellular calcium 
transients ([Ca2+]i) in response to neuronal stimulation (Cornell-Bell et al., 1990). With the 
development of genetically encoded Ca2+ sensors, such as GCaMP (Nakai et al., 2001) and 
improvements in imaging techniques (Bindocci et al., 2017) a plethora of studies was done, 
probing the pathways triggering astrocyte [Ca2+]i transients and their downstream effects.  
 One example are metabotropic glutamate receptors (mGluRs) such as mGluR5 - a 
neurotransmitter receptor expressed in astrocytes. Activation of mGluR5 results in [Ca2+]i 
transients in astrocytes, by release of Ca2+ from internal stores via the IP3 second-messenger 
pathway (Panatier et al., 2011; Porter and McCarthy, 1996). In turn glutamate-triggered [Ca2+]i 
transients have been linked to a number of effects such as changes in vasodilation (Attwell et al., 
2010; Mulligan and MacVicar, 2004) as well as influences on synaptic plasticity by release of 
transmitters such as D-serine, purines and glutamate itself (Di Castro et al., 2011; Jourdain et al., 
2007; Min and Nevian, 2012; Panatier and Robitaille, 2018; Pirttimaki et al., 2017). This 
mechanism of Ca2+ -dependent vesicular release of transmitters is called gliotransmission 
(Araque et al., 2014). The discovery of gliotransmission is in line with the functional assay 
proving that astrocytes in vitro use the most common pathway for Ca2+-dependent vesicular 
release, the SNARE complex (Schwarz et al., 2017; Zhang et al., 2004). This complex consists of a 
INTRODUCTION 
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set of proteins tethered to the inside of the cell membrane (syntaxin and SNAP-25) and to the 
outside of the vesicle membrane (synaptobrevin). Upon Ca2+ influx into the cell the complex is 
formed, and the vesicle can fuse with the membrane, emptying its cargo into the extracellular 
space (Jahn and Südhof, 1999). Together, these findings suggest, that astrocytes sense local 
neuronal activity through neurotransmitter receptors and directly react by gliotransmission to 
adjust local neurotransmission properties. 
 In vivo astrocyte [Ca2+]i imaging has confirmed that local glutamate signals enhance 
[Ca2+]i astrocyte activity, and found that locomotor activity can trigger [Ca
2+]i transients in vivo in 
the cerebellum (Nimmerjahn et al., 2009) as well as in the cortex (Paukert et al., 2014). In the 
latter case it was found that administering the broad inhibitor of adrenergic, serotonergic and 
histaminergic receptors, trazodone (Cusack et al., 1994), reduced locomotion-induced [Ca2+]i 
transients. Further studies showed that long-range cholinergic and noradrenergic (Ding et al., 
2013; Fellin et al., 2009; Takata et al., 2011) neuromodulatory inputs trigger astrocyte [Ca2+]i 
transients. This adds the incorporation of global inputs depending on brain states like 
wakefulness, to astrocyte functions (Papouin et al., 2017; Verkhratsky and Nedergaard, 2017). 
 Many of the downstream effects of [Ca2+]i-dependent release of transmitters from 
astrocytes have been assessed with the so-called dominant negative SNARE transgenic mouse 
line (dn-SNARE mouse). Since SNARE-dependent release from astrocytes has been shown to be 
the secretion mechanism in vitro, an in vivo model was developed where this mechanism is 
inhibited. In the dn-SNARE mouse the complex formation is blocked in astrocytes by transgenic 
expression of the untethered synaptobrevin recognition motif. The free cytosolic recognition 
motif forms the SNARE complex in the absence of vesicles and therefore prevents the complex 
formation with endogenous vesicle-tethered syntaxin (Pascual et al., 2005; Zhang et al., 2004).  
 With the dn-SNARE mouse it was demonstrated that neuronal transmission is directly 
affected when vesicular release from astrocytes is blocked. In hippocampal slice experiments 
from dn-SNARE mice, purinergic signalling from astrocytes tonically supresses synaptic 
transmission (Pascual et al., 2005). Moreover, astrocytes were identified as a source for 
extracellular D-serine, an NMDA-receptor co-activator. Blocking release mechanisms from 
astrocytes results in a decrease in extracellular available D-serine. As a result, less NMDA-
receptors could be activated and are available for NMDA-dependent long term potentiation 
(LTP). This finding is linked to the previously described long-range cholinergic inputs (Papouin et 
al., 2017).  
 The involvement of astrocytes in LTP-formation was moreover shown in a recent study 
using chemogenetic activation of CA1 astrocytes with designer receptors exclusively activated by 
INTRODUCTION 
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designer drugs (DREADDs). DREADD activation showed that astrocytes can trigger de novo LTP 
when stimulated, concluding that astrocyte activity alone is sufficient to trigger LTP in a [Ca2+]i 
dependent manner, supposedly by secretion of transmitters (Adamsky et al., 2018).  
 Taken together, these studies suggest a complex bi-directional communication between 
astrocytes and neurons. Astrocyte Ca2+ activity was shown to have in part opposing effects, as it 
may dampen or potentiate synaptic transmission (Papouin et al., 2017; Pascual et al., 2005). 
However, the exact mechanisms how these effects are orchestrated are not known. 
Nonetheless, these findings outline a model of astrocytes sensing global vigilance states and in 
response tune synaptic transmission accordingly. Thus, astrocytes increase the dynamic range of 
activity-induced synaptic plasticity (Bazargani and Attwell, 2016; Poskanzer and Yuste, 2016; 
Shigetomi et al., 2016). 
 
1.3 Gliotransmission: still an open question 
As outlined in the previous chapter, a number of bi-directional signalling pathways between 
astrocytes and neurons have been described. However, it is an ongoing discussion which 
signalling pathways are of functional relevance under physiological conditions, since most 
evidence was obtained either by artificial stimuli or in in vitro not reflecting all in vivo aspects. 
 There are several in vivo experiments that put some doubts on the postulated 
gliotransmission. One is the observation that KO-mice of the astrocyte specific IP3 receptor 
subtype 2 (IP3R2), show normal behaviour including regular learning and memory despite a 
substantial loss of [Ca2+]i signals in astrocytes. In brain slice experiments from IP3R2 KO animals, 
there hippocampal synaptic transmission and LTP was normal (Petravicz et al., 2008, 2014). This 
puts some doubts on the involvement of astrocyte [Ca2+]i dependent processes in complex 
cognitive functions. In line with this finding are the results from another transgenic mouse line 
targeting astrocytes (Fiacco et al., 2007). This mouse line expresses the spinal cord specific G-
protein coupled receptor (GPCR) MrgA1R in astrocytes of the forebrain. The MrgA1R ligand is 
not present in the forebrain unless provided experimentally. Experimental stimulation of 
MrgA1R receptors in the forebrain of the transgenic mouse resulted in [Ca2+]i transients in 
astrocytes, similar to transients evoked by glutamate in astrocytes of WTs. However, no effect 
on neuronal activity or synaptic transmission was found. Thus, it is not clear whether in vitro 
observed gliotransmission is of physiological importance (Fiacco and McCarthy, 2018). Likewise, 
strong stimulation of astrocytes using DREADDs may not reflect the physiological process 
(Adamsky et al., 2018). Another potential issue in gliotransmission research are manipulations 
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that may directly influence neurons. Fiacco et al argue, that for example the dn-SNARE mouse, 
which has been used in multiple studies to provide evidence of gliotransmission, is not strictly 
astrocyte specific, and the SNARE mechanism is also blocked in neurons (Fiacco and McCarthy, 
2018). Therefore, those experimental results have to be reviewed carefully and potential biases 
or unspecific side-effects of applied methods have to be revisited to avoid misleading 
conclusions concerning the effects on neuronal signalling based on altered gliotransmission.  
 Through the described controversy in published results it is obligatory, that tools to 
investigate astrocytes and the tri-partite synapse have to be carefully selected and that better 
tools are required to disentangle bi-directional astrocyte – neuronal communication.  
1.4 Astrocytes’ role in neuronal oscillations  
Neuronal ensembles describe subpopulations of neurons acting in synchrony and therefore 
giving rise to oscillation patterns that correlate with the behavioural performance (Buzsaki and 
Draguhn, 2004). Oscillations can be measured i.e. in vivo in electroencephalograms (EEGs) or in 
extracellular recordings in vivo or in brain slices. Whether astrocyte activity is correlated with 
neuronal oscillatory activity is still an open question.  
1.4.1 Neuronal oscillations 
Synchronous oscillatory brain states were first identified in “idling” brain states such as during 
sleep or anaesthesia (Steriade, 2001). Detailed biophysical studies revealed how single neurons 
adjust their electrophysiological properties to resonate with different types of oscillations 
(Buzsaki and Draguhn, 2004). Moreover, it was shown that the same neuronal oscillatory 
assemblies, active during sleep, were active in the wake phase. Thus, oscillations are thought to 
link single neuronal activity to global neuronal outputs such as behaviour, memory and learning 
processes and consciousness (Buzsaki, 2006). Disruption of oscillatory patterns in human EEG 
measurements have also been linked to neurological disorders such as schizophrenia, indicating 
oscillations to be necessary for maintaining physiological brain functions (Ahnaou et al., 2017). 
Different types of oscillations are known and range from 0.05 Hz to 500 Hz and are classified 
according to their frequency. These oscillations can occur simultaneously in different brain 
regions (Csicsvari et al., 2003; Steriade, 2001).  
 The presented study focuses on so called gamma oscillations that have a frequency 
range of 30 – 100 Hz and can be measured in humans in EEG as well as in rodents in both the 
cortex as well as the hippocampus. In rodents these oscillations in the hippocampus were linked 
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to specific behaviours. For example, gamma oscillations occur during exploration and typically 
coexist with theta oscillations (Bragin et al., 1995). 
 Gamma activity can be evoked in in vitro hippocampal slices through several types of 
manipulations including electrical or pharmacological manipulation (Bartos et al., 2007). 
Especially from pharmacological manipulations three prominent neurotransmitter receptors 
involved in gamma oscillations were identified; mGluRs, muscarinic acetylcholine receptor 
(mAChRs) and kainate receptors (kainate-R) (Fisahn et al., 1998, 2004; Whittington et al., 1995). 
For example, the mAChR agonist carbachol (CCH) induces gamma oscillations, which is thought 
to mimic cholinergic input in vivo from the septum to the hippocampus (Fisahn et al., 1998; 
Shute and Lewis, 1963). Gamma oscillations induced by CCH or mGluR stimulations are abolished 
by GABAA blockers, but only CCH-induced gamma oscillation is also blocked with AMPA receptor 
antagonists (Fellous and Sejnowski, 2000; Hájos et al., 2000). From these findings it can be 
concluded that the three different induction protocols result in gamma oscillations relying on 
different pathways. While kainite-R and mGluR induced gamma oscillations require only fast 
GABAA-mediated inhibitory pathways, thus most likely involving interneurons, the mAChR-
dependent gamma oscillations also rely on rapid excitatory signalling. All three forms are most 
likely relevant in vivo since gamma oscillations may occur in different state-dependent manners 
(Bartos et al., 2007).  
 From single cell electrophysiological recordings, it is known that principal neurons in CA3 
fire action potential phase-related to gamma oscillation, but each neuron only participates in 
approximately 5% of the cycles (Fisahn et al., 1998). 
 Another aspect investigated in context of the of gamma oscillations models is the 
involvement of gap-junctions between neurons. By pharmacological blocking gap-junctions the 
power of gamma oscillations was decreased. However, gamma oscillations where not entirely 
abolished (Traub et al., 2001). This was confirmed by the Cx36 deficient mouse line. Cx36 is 
thought to be mostly expressed in interneurons. Cx36 deficient mice had a significant decrease 
in gamma power compared with WT controls during wheel running. This suggests that Cx36 
interneural gap-junctions selectively contribute to gamma oscillations (Traub et al., 2001). 
1.4.2 Astrocyte activity during gamma oscillations 
Most of the published literature examined gamma oscillations in organotypic slice preparations. 
Therefore, astrocytes and other glial cells are also present in these slices and the applied 
manipulations also affected these cells. This fact however was not taken into consideration in 
the interpretation of these results. As described above it is well established, that astrocytes 
express a battery of neurotransmitter receptors (Verkhratsky and Nedergaard, 2017). Therefore, 
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pharmacological manipulations applied to trigger gamma oscillations could also trigger 
processes in the astrocytes which may contribute to the development of gamma oscillations in 
vitro. 
 Very little research has been done in elucidating astrocytes’ contribution to oscillatory 
brain states. It has been shown in one study by Poskanzer et al. that astrocytes-Ca2+-dependent 
pathways are required for cortical oscillatory state switches in vivo (Poskanzer and Yuste, 2016). 
By combining in vivo Ca2+ and glutamate imaging they could show that astrocytes release 
glutamate in a [Ca2+]i dependent manner. This, in turn triggers a neuronal circuit shift to slow 
oscillatory states, believed to be important for memory consolidation during slow wave sleep (Ji 
and Wilson, 2007; Poskanzer and Yuste, 2016). 
 Another study by Lee et al. focused on hippocampal gamma oscillations in slice cultures 
(Lee et al., 2014). In this study astrocyte [Ca2+]i activity was measured during CCH-induced 
gamma-oscillations. When vesicular release from astrocytes was blocked by lenti viral astrocyte-
specific expression of the toxic light chain of the tetanus neurotoxin (TeNT) from Clostridium 
tetani, the CCH-induced gamma oscillations were less persistent and did not last as long 
compared to control slices. This finding was confirmed in vivo with a triple transgenic mouse 
expressing astrocyte specific TeNT. EEG measurements in these mice showed reduced gamma 
power and behaviour experiments revealed impairments in novel object recognition. In 
conclusion this study links the lack of astrocyte [Ca2+]i-dependent release of glutamate to 
learning impairment by decreasing power in gamma oscillations. This study is in accordance with 
the findings from Poskanzer et al. who demonstrated the involvement of astrocytes in the 
regulation of oscillatory brain states (Poskanzer and Yuste, 2016). 
 However it still remains unresolved, how astrocyte [Ca2+]i activity is directly affecting 
neurons on a cellular level and how this activity can modulate oscillations. It is known that CCH-
induced gamma oscillations require both hippocampal excitatory and inhibitory circuits. Thus, 
the proposed model of glutamate gliotransmission could mean that neurons require the local 
glutamate signal from astrocytes to orchestrate their rhythmic activity by increasing the 
likelihood for action potentials of local neurons (Lee et al., 2014).  Other modes of interaction 
where for example astrocyte [Ca2+]i activity follows neuronal activity are possible as well 
(Poskanzer and Molofsky, 2018). With the current state of knowledge, however the link between 
the development of gamma oscillations and the involvement of astrocytes is missing. Identifying 
the cellular underpinnings of these regulatory mechanisms requires understanding both, the 
neuronal as well as the astrocyte contributions. 
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1.5 Retrograde tracer systems 
Despite countless investigations regarding the in vivo situation of the bi-directional astrocyte-
neuron communication, no clear conclusion is emerging. Both cell types are complex and derive 
from common precursor cells (Freeman, 2010), making any targeted manipulation prone to 
affect the other celltype, too. Distinguishing true effects from off-target effects is a major issue 
in this research field and faithful tools to perform this tasks have to be developed and carefully 
investigated. 
 In neuronal connectomics studies, retrograde tracer systems are used to dissect distinct 
neuronal ensembles. One example is the nontoxic heavy chain of the TeNT (TTC) which can bind 
to neuronal terminals and is readily internalized by the recycling of synaptic vesicles were the 
light chain exerts its toxic action by blocking the vesicle release (Price et al., 1975). Given that 
the bacteria are mostly found in soil and animal waste, the toxin usually takes a route from 
injuries in the periphery through the axon of motor neurons to be transported to the CNS (Lalli 
et al., 2003). The light chain of TeNT exerts the toxic effects by preventing the release of 
neurotransmitters from inhibitory neurons into the synaptic cleft. The effect is achieved by 
proteolysis of the SNARE proteins, required for the vesicular release (Munro et al., 2001). The 
TeNT heavy chain is non-toxic and facilitates binding and internalization of TeNT into the cytosol 
(Lalli et al., 2003). TTC binds with low affinity to polysialogangliosides (Herreros et al., 2000a) but 
protease experiments suggest the existence of another unidentified protein receptor bound by 
TTC (Herreros et al., 2000b). The uptake mechanism of the TTC is not entirely clear but existing 
data suggest two different uptake mechanisms a) in the presynapse in the neuromuscular 
junction, which as aforementioned is the usual first entry point and b) for entry into the axons of 
the interneurons in the CNS (Roux et al., 2006). The latter is thought to be depolarization and 
Ca2+ dependent (Miana-Mena et al., 2002).   
 By fusing the TTC fragment to reporter proteins like LacZ or GFP, the TTC fragment was 
used as a tracer as well as potential transporter for therapeutics (Kissa et al., 2002). Buettner-
Ennever et al. successfully transported TTC-coupled therapeutics as well as reporter proteins 
across the blood brain barrier, proving that the internalization mechanism exploited by TTC is 
not disturbed when fused to other proteins (Buettner-Ennever et al., 1981). A number of studies 
assessed neuronal connectivity by coupling to reporter proteins using different approaches, such 
as delivering the TTC fusion protein by directly injecting the purified protein (Perreault et al., 
2006), by transfection of an expression plasmid encoding the TTC-reporter into the peripheral 
tissue (Coen et al., 1997) or by engrafting eGFP-expressing cultured cells in the CNS (Kissa et al., 
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2002). These studies identified, for example, the connection of motor neurons and the brain 
stem (Coen et al., 1997) and CNS wiring of the striatum to motor cortex (Kissa et al., 2002).  
 The presented literature exclusively focused on the neuronal tracing properties of the 
TTC system. Astrocytes are in close contact to neurons as well as in close proximity to synapses. 
Moreover, they express and use vesicular release mechanisms similar to neurons in vitro and 
putatively in vivo. It is unclear however, whether the TTC fragment interacts with astrocytes and 
whether it is a feasible tool for defining the “connectome” of astrocytes. As mentioned above, 
tools to investigate astrocyte to neuron interaction suffer from non-specific targeting of applied 
manipulations. The TTC-tracer might be used to dissect astrocyte-neuron networks which are in 
direct contact to each other and thus potentially allow examining the minute details of their 
interaction. 
1.6 Objectives 
Astrocytes have been shown to respond to neuronal activity by [Ca2+]i transients, resulting in a 
number of different effects. However, the undisturbed physiological in vivo astrocyte-neuron 
interactions remain elusive due to limited accessibility. 
 In the presented study the bidirectional astrocyte-neuron communication was 
investigated in two different approaches. First, I tested on a histological level whether TTC can 
be exploited as a tool for specific targeting of astrocyte-neuron ensembles. The question was 
whether the eGFP-TTC fusion protein if delivered directly into the hippocampus is transferred 
“transsynaptically” a) from neurons to astrocytes, b) from astrocytes to neurons or c) from 
astrocytes to astrocytes. Results from these experiments can deliver proof of the existence of 
gliotransmission, since a “transsynaptic” transfer of the TTC-fragment from neurons to 
astrocytes, would show that astrocytes use similar release mechanisms as neurons in vivo. 
Moreover, TTC-mediated transfer from and to astrocytes poses a potential new labelling tool for 
distinct astrocyte-neuron ensembles, which could be used in future applications to elucidate the 
minute details of their interaction.  
 Second, I aspired to further investigate the interplay of astrocytes and neurons during 
gamma oscillations. Lee et al. proposed gliotransmission of glutamate to be a central 
contribution to gamma oscillations (Lee et al., 2014). The presented thesis aims to complement 
the findings by measurement of astrocyte [Ca2+]i transient simultaneously with neuronal [Ca
2+]i 
transient during CCH-induced gamma. The aim was to characterize astrocyte [Ca2+]i signalling 
properties such as frequency and kinetics change during gamma oscillations and to correlate the 
[Ca2+]i transients in astrocytes to the neuronal [Ca
2+]i transients. This could answer the question 
INTRODUCTION 
16 |  
 
whether [Ca2+]i-dependent glutamate release from astrocytes results in increased likelihood for 
neighbouring neurons to exhibit action potentials, which would indicate a mechanism of 
astrocyte control on gamma oscillation. Likewise, I asked whether the activity of a single 
astrocyte or an astrocyte population can be used as an indicator for different neuronal 
oscillatory states.  
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2. Results 
2.1 EGFP-TTC fusion protein: an astrocyte to neuron tracer? 
Astrocyte processes are not only in close proximity to synapses but have also been shown to 
react to neuronal activity and in turn manipulate how neurons react to neuronal activity 
(Shigetomi et al., 2016). The exact mechanisms how this interaction is fine-tuned remain 
unknown despite numerous studies (Jourdain et al., 2007; Panatier et al., 2011; Poskanzer and 
Molofsky, 2018; Volterra and Steinhäuser, 2004). A reason why the details remain elusive is the 
lack of specific tools to dissect distinct astrocyte-neuron pairs that are in direct contact to each 
other. In the presented study it was qualitatively tested whether the retrograde tracer molecule 
TTC coupled to the reporter protein eGFP can be used to identify distinct astrocyte-neuron 
ensembles. TTC could therefore serve as a tool to allow specific targeting of astrocyte-neuron 
ensembles. The eGFP-TTC protein was delivered via rAAV vectors allowing genetically targeted 
expression in neurons or astrocytes. Cell types of eGFP-positive cells were identified using 
immunohistochemical analysis. 
2.1.1 EGFP-TTC expression in neurons does not result in eGFP-TTC 
signal in astrocytes 
Perreault et al. have demonstrated that eGFP-TTC is transsynaptically transported from one 
neuron to another (Perreault et al., 2006). These studies focused on neurons and their 
connections to each other and a possible uptake of eGFP-TTC in astrocytes was not evaluated 
and has potentially been overlooked. In order to elucidate whether astrocytes are capable of 
eGFP-TTC uptake, it was transduced to neurons under the control of the neuron-specific 
synapsin promoter (figure 1A). The viral vector was injected unilaterally into the hippocampus of 
mice and the eGFP-positive cells were analysed three weeks later to determine cell types of 
eGFP-positive cells in both hemispheres. As expected, the injected hemisphere showed strong 
signal in the dorsal hippocampus close to the injection site (figure 1B, “IDG”, figure 1C.vi), but 
the signal was also located in the dentate gyrus (DG) of the ventral hippocampus (figure 1B, 
“iDG”) the entorhinal cortex (figure 1B, “iEC”) as well as the thalamus (figure 1B, “LD” and “LSr”). 
This indicates that the eGFP-TTC was transsynaptically transported to these regions, which are 
known to be connected to neurons in the hippocampus (Witter, 1993). Also, neurons in the 
contralateral CA region and DG of the hippocampus (both dorsal and ventral) as well as the 
ventral entorhinal cortex were eGFP-TTC positive (figure 1B,C, “cDG”, “cEC”). The contralateral 
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signal was weaker, compared to the signal in the ipsilateral hemisphere. The spread and pattern 
of the signal shows, that the eGFP-TTC is transported across synapses. Hippocampal neurons are 
known to project via the Schaffer collaterals to the hippocampus of the other hemisphere. 
Therefore, the eGFP-TTC can access these neurons by retrograde transport along synapses with 
primarily infected starter neurons in the rAAV-injected hippocampus.  
 
Notably, the dorsal fornix, the main output fibre bundle from the hippocampus, connecting the 
two hemispheres, was clearly eGFP-TTC positive in the injected hemisphere (figure 1B, “DF”, 
Figure 1: eGFP-TTC expressed in neurons is transmitted across synapses. A) Schematic representation of injected rAAV 
construct. B) Representative horizontal dorsal and ventral  sections from animals injected with rAAV-syn-eGFP-TTC. 
Slice coordinates on dorso-ventral axis (DV) indicated. The eGFP-TTC signal is observed in the dorsal hippocampus in 
both hemispheres. Even in the ventral hippocampus the eGFP-TTC signal was found in ipsi- and contralateral DG (iDG, 
cDG) as well as in the entorhinal cortex (iEC, cEC). Diffuse eGFP-TTC signal was observed in the lateral septal nucleus 
(LS) and lateral dorsal nucleus of thalamus (LD). Scale bars 500 µm.  C) close-up images of indicated rectangles i-vi. In 
the CA1 pyramidal layer (py) neurons but no astrocytes were eGFP-TTC positive in both hemispheres. In the injected 
hemisphere the DG (iDG) was found to have many eGFP-TTC-positive neurons in the granular layer (gr) and the 
polymorph layer (po), while on the contralateral hemisphere only the polymorph layer eGFP-TTC-positive neurons were 
observed. Dorsal fornix fibers (DF) only in the injected hemisphere were observed. Neither region showed eGFP-TTC-
positive astrocytes. Scale bars 50 µm. Or: stratum oriens py: pyramidal layer, ra: stratum radiatum. 
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figure 1C.iv). It has to be noted though, that direct infection of axon terminals is another possible 
access route to these neurons as rAAV1/2 serotype can infect axon terminals, albeit with low 
efficiency (Tervo et al., 2016). The observation of eGFP-TTC signal in the contralateral entorhinal 
cortex, however is a clear indication, that the eGFP-TTC must have crossed at least one or more 
synapses. High magnification imaging identified the eGFP-TTC-positive cells in both hemispheres 
to be neurons (figure 1C). It has to be noted that the location of eGFP-TTC positive neurons in 
the contralateral DG compared to the ipsilateral DG differ as shown in figure 1C.v and C.vi. While 
in the injected hemisphere eGFP-TTC neurons were located in the granular layer as well as in the 
polymorph layer of the DG, in the contralateral hemisphere the granular layer was void of eGFP-
TTC-positive cells.  
In both hemispheres no eGFP-positive astrocytes were observed. This suggests that the 
transport of the eGFP-TTC signal from one starter neuron to the next neuron, travelling 
comparably large distances to regions outside the injected hippocampus, occurs completely 
without any astrocyte involvement. This means that despite considering astrocytes to be active 
partners at the synapse, they are not involved in those aspects of synaptic transmission that the 
TTC fragment exploits for retrograde transsynaptic transport.  
2.1.2 EGFP-TTC expression in astrocytes 
Although eGFP-TTC protein expression in neurons does not result in eGFP-positive astrocytes, 
the question remains whether eGFP-TTC when expressed in astrocytes is transferred to other 
cells and if so, to which cell types. To investigate this, the eGFP-TTC construct was expressed 
under the control of the astrocyte-specific glial fibrillary acidic protein (GFAP) promoter (figure 
2A). The immunofluorescence analysis of rAAV-GFAP-eGFP-TTC injections showed strong eGFP-
TTC signals in astrocytes and comparably weaker signals in pyramidal neurons in the CA1 cell 
layer of the injected hippocampus (figure 2B, C). Moreover, there was diffuse eGFP-TTC signal in 
regions outside of the hippocampus in the retrosplenial cortex as well as the thalamus (figure 2B 
“LD”, “RSP”). Interestingly, there were eGFP-TTC-positive neurons in the pyramidal cell layer of 
the contralateral hemisphere (figure 2C) and the dorsal fornix of the ipsilateral hemisphere was 
eGFP-TTC positive (figure 2B, “DF”), similar to the previous observation with eGFP-TTC 
expression in neurons.  
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Immunofluorescence labelling against the astrocyte specific GFAP protein as well as the 
morphology clearly identified neurons in the contralateral CA regions, indicating that eGFP-TTC 
was transported to these cells, by transsynaptic transport. In control experiments animals were 
injected with rAAV-expressing only the uncoupled eGFP reporter (rAAV-GFAP-eGFP, figure 3A).  
Figure 2: eGFP-TTC-expressed in astrocytes results in eGFP-TTC-positive neurons. A) Schematic representation of rAAV 
construct. B) Representative coronal and horizontal sections from animals injected with rAAV-GFAP-eGFP-TTC. Slice 
coordinates on anterior-posterior (AP) and dorso-ventral (DV) axis indicated, respectively. The eGFP-TTC signal was 
observed in astrocytes and neurons the hippocampus of the injected hemisphere (CA1, iCA3, DG). eGFP-TTC-positive 
astrocytes were also observed in the ipsilateral cortex together with non-cellular eGFP-TTC-positive structures spreading 
along the retrosplenial cortex (RSP) and lateral dorsal nucleus of the thalamus (LD) and the entorhinal cortex (EC). eGFP-
TTC-positive neurons but not astrocytes were observed in the hippocampus contralateral to the injection site (cCA3) and 
eGFP-TTC signal was observed in the dorsal fornix (DF), both indicating the presence of eGFP-positive neurons projecting 
to the contralateral hemisphere. Scale bars 500 μm. C) High magnification images of the ipsi- and contralateral 
hemisphere showed eGFP-TTC-positive CA1 pyramidal neurons and astrocytes in the ipsilateral hemisphere. In the 
contralateral hemisphere only eGFP-TTC-positive neurons were observed. Scale bar 50 µm. “Or”: stratum oriens “py”: 
pyramidal layer, “ra”: stratum radiatum. 
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In these brains the CA region of the injected hemisphere and the contralateral hemisphere are 
completely devoid of eGFP-positive signals as shown in figure 3B and C. Immunofluorescence 
labelling of GFAP, identified all eGFP-positive cells as astrocytes as shown in the high 
Figure 3: eGFP expression in astrocytes is restricted to the hippocampus but shows non-specific expression in DG 
neurons. A) Schematic representation of rAAV construct. B) Representative coronal and horizontal sections from 
animals injected with rAAV-GFAP-eGFP. Slice coordinates on anterior-posterior (AP) and dorso-ventral (DV) axis 
indicated, respectively. The eGFP signal was observed in astrocytes only in the hippocampus (CA1, DG) of the injected 
hemisphere but not outside of the hippocampus or in the contralateral hemisphere. Scale bars 500 μm. C) High 
magnification images of the ipsilateral CA1 pyramidal cell layer (indicated by dotted line) showed that there were not 
eGFP-positive neurons. Scale bar 50 μm. Or: stratum oriens, py: pyramidal layer, ra: stratum radiatum. D) High 
magnification images of the ipsilateral granular cell layer of the DG (dotted line indicates border between polymorph 
layer (po) and granular layer(gr)) showed that some neurons express the eGFP protein (examples indicated with 
arrowheads). Scale bar 100 µm. 
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magnification images in figure 3B. Another striking difference is the overall spread of the eGFP 
signal. In case of the rAAV-eGFP virus the signal is confined to the injection site in the 
hippocampus (figure 3 B), whereas the eGFP-TTC fluorescence besides the labelling of the 
contralateral neurons, is more spread out towards the subiculum of the injected hippocampus 
(figure 2B, “Sub”), which is connected to the CA1 region as well as the entorhinal cortex (Witter, 
1993).  
While on the first sight this observation could mean that eGFP-TTC expressed in 
astrocytes is not confined to starter cells (cells expressing the rAAV construct), a closer analysis 
of the granular cell layer of the DG gives another explanation. The granular layer of the DG in the 
control mouse showed eGFP positive cells, which were identified as neurons by 
immunofluorescence labelling for NeuN (figure 3D, arrowheads). This observation challenges the 
conjecture of the strictly astrocyte-specific expression of the constructs in this region. The eGFP-
TTC-positive cells in brains injected with the rAAV-eGFP-TTC could therefore occur due to 
nonspecific expression in neurons in the DG. Since eGFP-TTC is known to cross synapses from 
one neuron to another (see figure 1 or Perreault et al., 2006), the signal may travel from the DG 
via interneurons to the other brain regions, which explains the wide distribution of eGFP-TTC-
positive cells in different brain areas as observed when eGFP-TTC is expressed with the GFAP 
promotor (figure 2).  
2.1.3 Specific eGFP-TTC expression in astrocytes of ALDH1/1-CreERT2 
mice 
In order to avoid non-specific expression of the eGFP-TTC fusion protein as observed in 
the previous experiments, the ALDH1/1-CreERT2 inducible transgenic mouse line was employed. 
This mouse line expresses the tamoxifen inducible cre-recombinase (CreERT2) exclusively in 
astrocytes (Srinivasan et al., 2016). A new rAAV vector was constructed where the eGFP-TTC 
gene is flanked by two cre-recombinase recognitions sites (loxP, lox2272) in a double-inverted 
orientation (rAAV-GFAP-eGFP-TTC-DIO) (figure 4A). The rAAV-GFAP-eGFP-TTC-DIO was injected 
in the hippocampus at the same coordinates as in the previous experiments (figure 4B). One 
week after injection the cre activity of CreERT2 was activated by tamoxifen administration and 
three weeks later brains were analysed. 
As expected the immunohistological staining of brain sections showed a high number of 
eGFP-positive astrocytes but in cotrast to rAAV-GFAP-eGFP-TTC injected wild-type mice (figure 
2) no neurons were EGFP-TTC positive(figure 4B). Immunofluorescence labelling of the GFAP 
protein showed that all eGFP-TTC positive cells are also GFAP positive (figure 4B, close-ups). 
There was no signal in the pyramidal cell layer of the CA-regions in neither hemisphere and 
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neuronal cell bodies are clearly omitted. It has to be noted, however that despite the absence of 
cre-recombinase in control 
 
Figure 4: Only eGFP-TTC-positive astrocytes but not neurons were observed in rAAV-eGFP-TTC-DIO- injected brain of 
ALDH1/1-CreERT2 mouse. A) Schematic representation of injected virus GFAP-eGFP-TTC-DIO induction. B) Top images 
show overviews of horizontal sections. Slice coordinates indicated on dorso-ventral (DV) axis. Scale bar 500 µm. While 
many eGFP-TTC-positive cells were observed in the CA region of ALDH1/1-cre mouse and very few eGFP-TTC positive 
cells in WT mouse. This indicates a low level of non-specific expression of the injected rAAV-eGFP-TTC-DIO. No eGFP-
TTC signal was observed in the contralateral hemisphere. Co-localization with immunofluorescence signals for GFAP 
identifies only astrocytes in the ALDH1/1-cre to be positive for eGFP-TTC. Cell types of the non-specific eGFP-TTC 
expressing cells in WT animals could not be identified. Scale bar bottom two rows 100 µm. Or: stratum oriens, py: 
pyramidal layer, ra: stratum radiatum. 
experiments with the rAAV-eGFP-TTC-DIO in a WT mouse without cre-recombinase (figure 4B 
and C) showed two eGFP-TTC-positive cells, indicating a low level of non-specific expression. The 
cell type of these cells could not be determined, as these cells were not positive for any 
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established immunolabelling assay, nor matched the morphology of a certain cell type. 
Compared to the amount of signal observed in the tamoxifen induced ALDH1/1-Cre-ERT2 mouse 
the non-specific expression was very low and since there were no eGFP-TTC-positive neurons in 
the ALDH1/1-Cre-ERT2 mouse, this low-level non-specific expression of the eGFP-TTC-DIO 
construct does not result in false-positive neurons. 
It can be concluded from these experiments that the eGFP-TTC does not jump from 
astrocytes to neurons. The previous results were most likely the effect of non-specific expression 
of the rAAV construct in granular cells of the DG.  
2.1.4 Labelling starter cells with “2A-KusO” 
The previous experiments have shown that eGFP-TTC expressed in astrocytes is not transmitted 
to neurons and vice versa, expression in neurons does not result in eGFP-TTC labelled astrocytes. 
However, eGFP-TTC expressed in astrocytes shows a remarkable spread of the signal in the 
ALDH1/1-Cre-ERT2 mice. The question remains whether all eGFP positive astrocytes express the 
construct or if some of them received it by intercellular transport mechanisms.  
 In order to distinguish rAAV-expressing starter cells, from those cells receiving the eGFP-
TTC fusion protein, another construct was cloned including a second immobile reporter. This 
reporter is the kusabira orange (KusO) fluorophore which is concatenated to the eGFP-TTC 
construct with the transscriptional-skipping T2A-peptide sequence (Wang et al., 2015). Since the 
two proteins are separately translated by ribosomal skipping the eGFP-TTC is free for transport 
into another cell, while the KusO-reporter stays behind in the starter cell. This allows distinction 
of cells expressing the rAAV construct, positive for both eGFP and the KusO reporter, from cells 
receiving the eGFP-TTC fusion protein via transsynaptic transport, which are only eGFP positive. 
This approach not only allows identification of those astrocytes which receive the eGFP signal 
from neighbouring astrocytes (figure 5) but may also confirm the previously observed leak 
expression in neurons.  
 The eGFP-TTC-2A-KusO virus was injected in hippocampi of adult mice and brains were 
dissected and sliced 2 – 3 weeks after injection (figure 5). It was observed that similarly to the 
ALDH1/1-cre-ERT2 experiment, the eGFP-TTC signal was only observed in the injected 
hemisphere with a tendency to spread towards the subiculum (figure 5B, “Sub”). A number of 
clearly double-labelled astrocytes as well as neurons in close proximity to the injection site were 
observed (figure 5C arrowheads, asterisk). In contrast to the injections with rAAV-GFAP-eGFP-
TTC (figure 2), the injection site appears damaged and surprisingly the KusO-reporter is located 
extracellularly and in the absence of eGFP signal (figure 5C, arrows). This suggests toxic effects of 
the KusO-reporter and that cells expressing the construct had died during the incubation period 
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which is a problem often observed with red-shifted fluorescent reporters (Shemiakina et al., 
2012). While the double-labelled neurons (figure 5C, asterisk) indicate again that the construct is 
non-specifically expressed as seen with the rAAV-GFAP-eGFP-TTC (figure 3), the general tissue 
damage makes interpretation of these results difficult.  
 
Figure 5: Fluorescence images of brain injected with rAAV-eGFP-TTC-2A-KusO. A) Schematic representation of 
injected virus GFAP-eGFP-TTC-2A-KusO. B) Overview of horizontal section at coordinates on dorso-ventral (DV) axis as 
indicated. EGFP-TTC and 2A signal is located in the injected hemisphere close to the injection site and in the subiculum 
(Sub). Scale bar 500 µm. C) High magnification images of the injections site show beside double positive astrocytes 
(arrowheads) and double positive neurons (asterisk) extracellular red fluorescent particles (arrows), indicating cell 
death of KusO expressing cells. Scale bar 200 µm.  Or: stratum oriens, py: pyramidal layer, ra: stratum radiatum. 
Extracellularly located fluorophore proteins could be picked up by surrounding cells and give rise 
to false positive cells. The same is true for the surrounding astrocytes making it impossible to 
distinct starter astrocytes and astrocytes which received eGFP-TTC by cell-to -cell contact. 
Almost all astrocytes in close proximity to the injection site were weakly labelled with the red-
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fluorophore. On the one hand this could mean that only cells with low expression level survived 
the incubation time. On the other hand, as aforementioned endocytosis of fluorophore proteins 
from the extracellular space could also result in a weak labelling of these cells. It is however 
worth to mention that the eGFP-signal spreads much further along the subiculum compared to 
the KusO signal (figure 5B, “Sub”). Cells in these more distal areas are exclusively non-neuronal, 
suggesting that the eGFP-TTC signal spreads from starter cells, whichever they are, to these 
astrocytes. Nonetheless, the fluorophore-triggered cell death alters the cell physiology 
compared to previous injections and these results do not reflect the undisturbed in vivo 
situation. Therefore, this construct does not allow the clear distinction between starter cells and 
target cells. 
2.1.5 Combined fluorescence in situ hybridisation-immunofluorescence  
Since distinction of 
rAAV-expressing cells and 
potential eGFP-TTC-targeted 
cells proved to be difficult 
another approach was applied. 
To solve the question whether 
transport of eGFP-TTC from 
astrocytes to other cells takes 
place, a combination of eGFP 
immunofluorescence labelling 
and fluorescent labelling of the 
eGFP mRNA by in situ 
hybridization (FISH-IF) was 
established using the 
RNAscope® FISH assay. In 
contrast to tracer studies dissecting strictly neuronal connections, the target cells of astrocytes 
are potentially in close proximity to the starter astrocyte cell. In the previous experiments the 
injection site showed a great number of eGFP positive cells, making identification of single cells 
even with confocal microscopy difficult. To allow better read-out of the combined FISH-IF assay a 
sparse expression of the eGFP-TTC is desirable.  Therefore, a modified eGFP-TTC expression 
system was used for the FISH-IF assay. This system is a combination of the cre-dependent rAAV-
eGFP-TTC-DIO (see results 2.3.1) and another much more diluted rAAV expressing cre-
recombinase (rAAV-GFAP-CRE) (figure 6A). The ratio of the two viral titres was experimentally 
Figure 6: 75:1 ratio of rAAV-GFAP-eGFP-TTC-DIO and rAAV-GFAP-Cre-
recombinase results in sparse but intense eGFP-TTC expression. 
Representative coronal section (slice coordinates on anterior-posterior (AP) 
axis as indicated) with EGFP-positive cells, sparsely distributed in the injected 
hippocampus. CTX: cortex, or: stratum oriens, py: pyramidal layer, ra: 
stratum radiatum. Scale bar 200 µm 
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tested and matched to allow expression of eGFP-TTC in only very few cells. Since the rAAV-eGFP-
TTC-DIO is not diluted, these the rAAV-eGFP-TTC-DIO cells have a high copy number of eGFP-
TTC-DIO and are expected to have high eGFP-TTC expression when activated by Cre. Cre-
recombinase was delivered via rAAV expression under control of the GFAP promotor, therefore 
an additional level of expression control is added to the system as well. Different ratios of the 
cre-expressing and the cre-dependent virus were tested (1:25, 1:75, 1:100, 1:400) and a ratio of 
1 part cre-expressing virus to 75 parts cre-dependent virus resulted in a sparse but intense 
labelling of cells as shown in figure 6B. For the following FISH-IF experiments the two viruses 
were used with this ratio.  
The FISH-IF assay was performed according to the manufacturer’s instruction with 
modified incubation steps as described in material and methods (chapter 4.3.2), using the eGFP 
probe. Since rAAVs infect cells in an unspecific manner the viral DNA is abundant in all cells in 
the injection site. Therefore, a DNase step was included before the FISH assay was performed. 
Additionally, an eGFP-sense probe was used as negative control. The sense probe is identical to 
the mRNA and can therefore only detect eGFP-encoding DNA. Any signal obtained with the 
sense probe is therefore false positive DNA detection and these experiments served to estimate 
the background FISH signal from DNA-contamination. As shown in figure 7B the RNAscope® 
signal with the RNA-detecting eGFP-probe was observed in the CA1 region of the injected 
hippocampus. The eGFP antisense probe was co-localized with cell bodies positive for eGFP 
immunofluorescence signal (figure 7B, arrowheads). However, essentially all cells in the 
pyramidal cell layer were positive for the FISH-eGFP signal while showing no 
immunofluorescence signal, indicating false positive detection with the RNAscope® assay. 
Indeed, the negative control with the eGFP-sense probe showed similarly strong signal in the 
CA1 region, providing strong evidence that the RNAscope® assay was not restricted to RNA 
detection but also detects the high copy numbers of eGFP-encoding rAAV genomes that were 
delivered to astrocytes and neurons (figure 7C). This is surprising since the DNase treatment 
should have avoided this false positive detection. This means that it is not possible to distinguish 
FISH-eGFP-positive cells containing mRNA from those giving a false positive signal due to high 
rAAV genome load. Therefore, the combined FISH-IF approach could not clarify which cells 
express the viral DNA and which receive eGFP signal transsynaptically.  
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 Figure 7: Combined FISH-eGFP signal and IF-GFP signal does not co-localize. A) Schematic representation of injected 
virus rAAV-GFAP-Cre and rAAV-GFAP-eGFP-TTC-DIO in a 75:1 ratio. B) All cells within the injected area had FISH –signal 
with the antisense eGFP probe (B). While all IF-positive cells co-localize with FISH-signal (B arrowheads in close-up), 
FISH signal is observed also in cells with no IF signal e.g. in the pyramidal cell layer, indicating false positive FISH 
detection (B, “py”). Control experiments with the DNA detecting sense probe (C) confirm strong false positive 
background from DNA signal contamination (C arrowheads in close-up). Scale bars B,C top: 200 µm, close-ups 50 µm. 
Or: stratum oriens, py: pyramidal layer, ra: stratum radiatum. Slice coordinates indicated on anterior-posterior (AP) 
axis.    
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2.2 [Ca2+]i signals during gamma oscillations 
Gamma oscillations are concerted neuronal activity patterns, which can be measured in in vivo 
as well as in vitro. While the exact mechanisms of their generation are is still not resolved, it has 
been shown, that hippocampal gamma oscillations play an important role in memory and 
learning processes (Buzsaki and Draguhn, 2004). Since astrocytes are regarded as an active 
partner in synaptic transmission, and are linked to brain state switches, the possibility of a direct 
correlation of the astrocytic [Ca2+]i transients and gamma oscillations was investigated. While 
Lee et al already showed on a single cell level that astrocytic [Ca2+]i transients precede the 
occurrence of gamma oscillations (Lee et al., 2014), I investigated in hippocampal slice cultures 
how the whole astrocyte population behaves during CCH-induced gamma oscillation (CCH-GM). 
Moreover, I investigated whether astrocyte [Ca2+]i transients correlate with neuronal [Ca
2+]i 
transients. To achieve this, the virus encoded Ca2+ indicators GCaMP6f and jRGeco1a were 
delivered to astrocytes and neurons, respectively, in hippocampal organotypic cultures by co-
infection with rAAV-GFAP-GCaMP6f and rAAV-Syn-jRGeco1a (figure 8A). After 14-21 days the 
astrocytic [Ca2+]i and neuronal [Ca
2+]i activity was monitored while measuring the local field 
potential (LFP) during CCH-GM (figure 8,B).  
 
Figure 8: Parallel recording of [Ca
2+
]i transients in astrocytes and neurons. A) Schematic representation of rAAV-
GFAP-GCaMP6f and rAAV-Syn-jRGeco1a used for cell specific expression of the colour shifted Ca
2+
 indicators. B) 
Maximum intensity projection of both imaging channels from a representative recording with the detected ROIs 
indicated (white outlines) shows the two non-overlapping cell populations. Position of the field electrode is indicated in 
merge image. Scale bar: 50 µm. 
Recordings were performed in a submerged imaging chamber for 6.5 minutes during which CCH 
was washed into the chamber for gamma oscillation induction and was continued to be washed 
in until the end of the recording. Figure 9 illustrates schematically the simultaneous 
measurements and the wash in of CCH. The field electrode was placed in the CA3 region of the 
slices as gamma oscillations are thought to be generated in this region (figure 8B). In order to 
analyse the Ca2+ signals of both astrocytes and neurons, the Ca2+ imaging data were pre-
processed with MATLAB using the customized constrained non-negative matrix factorization 
method (CNMF) described by Pnevmatikakis et al., 2016. The processing step defines ROIs and 
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extracts their respective relative fluorescence over time. This method also includes image 
normalization and demixing of signals from overlapping ROIs. Spatial segmentation results are 
shown for the example in figure 8B with white outlines around the respective ROIS.  
 
 
Figure 9: Experimental set up. Local field potential (depicted as blue trace on top) is recorded simultaneously with Ca
2+
 
transients from astrocytes and neurons. At the beginning of the 6.5 minute experimental session the slice is untreated. 
After approximately 1 minute CCH is washed in. 
 
ROIs are mostly round regions with different diameters between approximately 2-15 µm for 
astrocytic ROIs and 2 – 30 µm for neuronal ROIs. Based on size and morphology one can 
conclude that the astrocytic ROIs are mostly microdomains of astrocyte processes, which is in 
line with accounts of astrocytic [Ca2+]i  transients in the literature (Tang et al., 2015). In case of 
the neuronal ROIs, sizes and shapes vary greatly and judging from morphological features, some 
ROIs appear not plausible as there are no neuronal cell bodies but only neuropil present. 
Therefore, an additional manual validation step was included in the image processing to exclude 
ROIs which are clearly not of somatic origin. Another observation is that due to the lack of Ca2+ 
indicator in the neuron’s nuclei, the segmentation in some cases detects only half the neuronal 
cell body. While this should not affect the [Ca2+]i read out, ROI sizes were not evaluated, since 
splitting of ROIs renders the read-out unreliable.  
 
2.2.1 Astrocytic and neuronal population stability differs over two 
recordings 
Depending on the experiment type and the state of the respective slice, some slices were 
imaged twice for 6.5 minutes. The ROI extraction was performed for each recording 
independently regardless of whether or not the slice had been recorded twice in a row. Thus, it 
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was possible to compare the ROI detection results for those slices that have been recorded 
twice. It was determined, whether the same astrocytic ROIs and neuronal ROIs that are active in 
the first recording, are also active in the following imaging interval, or whether the population of 
active ROIs differs. 
 
Figure 11: Overlaps of detected astrocytic and neuronal ROIs of 16 slices recorded twice consecutively. Astrocytic 
ROIs were found to vary more over the course of two recordings whereas neuronal ROIs are more stable and are 
mostly detected in similar locations in both recordings. 
 
While the overlap of astrocytic ROIs was comparably low, 
the neuronal ROIs appeared much more stable as shown in 
the 16 pictographs (figure 11) indicating the ROIs position in 
the fields of view in the first imaging session (blue), the 
second (green) and their overlap (yellow). The median 
overlap of the neuronal ROIs between first and second 
recording from 16 pairs of experiments was 75.14% (+- 
13%) while the astrocytic ROIs only had a median overlap of 
36.9% (+- 19%)(figure 10). The observation that most 
neuronal ROIs were detected in two independent 
measurements and processing rounds, means that the 
population of active neurons is stable, and cycles of activity 
are shorter than the recording time. The population of 
active astrocytic ROIs is much more inconsistent in the first 
and second recording. This could mean that the cycle for 
Figure 10: Astrocytic ROIs of two 
subsequent imaging sessions were less 
overlapping than neuronal ROIs. Red line 
depicts the median overlap, blue box is the 
25th and the 75th percentile, whiskers 
depict most extreme values, not 
considered outliers. Outliers labelled as red 
cross. 
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recurrent activity of one particular ROI is longer than the imaging period, or that ROIs which are 
active at some point cease their activity altogether, while new ROIs become active. It must also 
be taken into consideration, that the two recordings were completed under different conditions, 
with different pharmacological agents. Nonetheless, this finding indicates that in contrast to the 
neuronal population the astrocyte population is more instable and reacts differently to the 
applied conditions.  
2.2.2 Changes in [Ca2+]i activity over time in astrocytes and neurons  
Besides the spatial distribution the temporal distribution of astrocytic [Ca2+]i signals in respect to 
CCH-GM was analysed. To this end, the astrocytic as well as the neuronal [Ca2+]i signals of each 
ROI over time were analysed.Figure 12A and B top panels show the colour coded relative 
fluorescence intensity over time of each ROI depicted in figure 8B for astrocytic and neuronal 
ROIs, respectively. Peaks in the relative intensity were extracted for each ROI with a custom-
made MATLAB script and pooled in a binarized “spike-matrix” (figure 12A, B lower panel).  
Figure 12: Relative intensity over time and LFP during CCH-GM. A and B show the relative intensity over time for 
astrocytic ROIs (A) and neuronal ROIs (B) Top panel: each row represents a single ROI. Lower panel indicate where 
peaks are detected in the relative intensity over time pooled for all ROIs, respectively. C) Power spectrum density of the 
LFP with a clear 30 Hz band between 200 and 360 s occurring after CCH application.A total of 11 experiments were 
performed with this condition. 
The LFP recordings were low pass filtered and the power spectrum density was calculated, which 
is shown for this example infigure 12C. In this representative experiment the first 30 s were the 
pre-treatment time window. At 30 s CCH was washed in. The acute wash in phase first resulted 
in a state with no prominent oscillatory pattern, visible in the power spectrum with low values 
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between 30s and 60s. Usually a large number of astrocytes and neurons reacted with a brief 
increase in [Ca2+]i activity in this phase. The development of gamma oscillations was observed at 
approximately 60 s where the 40 Hz frequency band showed a higher power density. This shifts 
towards 30 Hz through the course of the recording and becomes strongest between 200 and 
360s. For the further analysis time windows were defined according to the oscillatory states of 
the respective slice. The time windows with no treatment were defined as “pre-treatment”. In 
this group two experiments with no pharmacological treatment throughout the recording were 
included. For analysis of CCH-GM only those time windows with stable 30 Hz gamma oscillations 
were used, as is the case between 200 – 360s in this example, while the acute wash-in phase 
was not included in the analysis. For each experimental condition the total number of peaks per 
time was normalized to the number of ROIs (further referred to as pks/s).  
Astrocytes are known to express a number of neurotransmitter receptors which in turn 
can trigger Ca2+ transients, which means that the wash in of CCH itself can result in [Ca2+]i 
transients (Shelton and Mccarthy, 2000). In order to discriminate the direct effects of CCH on 
astrocytes, in control experiments TTX, a blocker of voltage gated sodium channels (Lee and 
Ruben, 2008), was washed in before the CCH was applied (further referred to as TTX condition).  
 
 
Figure 13: Relative intensity over time and LFP during TTX. A and B show the relative intensity over time for astrocytic 
ROIs (A) and neuronal ROIs (B) Top panel: each row represents a single ROI. Lower panel indicate where peaks are 
detected in the relative intensity over time pooled for all ROIs, respectively. C) Power spectrum density of the LFP has 
only a band at 50 Hz with comparably weak power, indicating that only 50 Hz noise oscillations were present. A total 
of 4 experiments were performed with this condition.  
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Thus, neuronal signal transduction and the development of gamma oscillations is supressed. The 
relative fluorescence of astrocytes and neurons as well as the power spectrum density of the LFP 
were analysed for TTX experiments similarly as the CCH-GM experiments. A representative TTX 
experiment is shown in figure 13. As expected the power spectrum density of the LFP did not 
show a prominent oscillatory pattern except for the comparably weak 50 Hz band that occurs 
due to noise in the recording. 
Moreover, as another control experiment the GABAAR antagonist gabazine (GBZ) was 
used. GBZ is known to trigger epileptiform activity in organotypic slices by disinhibiting the slice 
(Glykys and Mody, 2007). In this model for synchronized neuronal activity, neurons fire together 
in a highly synchronized burst like manner. This was measured similarly to the CCH-GM and TTX 
experiments. The relative fluorescence of the neuronal ROIs was observed to coincide with the 
epileptiform activity bursts in the LFP measurement (figure 14).  
 
Figure 14: Relative intensity over time and LFP during GBZ. A and B show the relative intensity over time for astrocytic 
ROIs (A) and neuronal ROIs (B) Top panel: each row represents a single ROI. Lower panel indicate where peaks are 
detected in the relative intensity over time pooled for all ROIs, respectively. C) Power spectrum density of the LFP 
shows recurring synchronous events upon GBZ wash-in which are synchronized with the neuronal peaks in the relative 
intensity. A total of 3 experiments were performed with this condition.  
 For all four conditions; pre-treatment, CCH-GM, TTX and GBZ, the mean number of 
[Ca2+]i
  pks/s was calculated for astrocytic and neuronal ROIs, respectively (figure 15). The 
number of [Ca2+]i pks/s of astrocytic ROIs during the pre-treatment (0.21 ± 0.11 x10
-3 pks/s) did 
not significantly differ from the number of [Ca2+]i pks/s during CCH-GM (0.63 ± 0.18 x10
-3 pks/s).  
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Figure 15: Number of peaks in the relative fluorescence intensity per time and per ROI of astrocytes and neurons 
does not differ in all four conditions. Boxplots overlaid with data points from each experiment.(Red line depicts the 
mean, coloured box is the 1.96 SEM, blue frame is the 1xSD) shows no significant differences in the number of pks/s in 
the pre-treatment (Pre-, n=20), during CCH-induced gamma oscillation (CCH-GM, n = 11 slices), TTX (n = 4 slices) and 
GBZ (n = 3 slices).  
However, there was a trend of increased astrocytic activity (figure 15). In the TTX experiments, 
there was no significant change in the overall number of astrocytic pks/s compared to the pre-
treatment time windows, but a trend towards a slight increase in the activity (0.54 ± 0.21 x10-3 
pks/s) was observed, similar to the CCH-GM condition. This means that the trend observed in 
CCH-GM experiments can be explained by direct stimulation of AChRs on astrocytes and that it is 
not the gamma oscillation itself resulting in the increase trend of [Ca2+]i pks/s seen in CCH-GM. In 
the gabazine condition again, the number of astrocytic [Ca2+]i pks/s (0.42 ± 0.09 x10
-3 pks/s) was 
not significantly in- or decreased compared to the pre-treatment.  
The same analysis was done for the neuronal Ca2+ signals. In contrast to the astrocytic 
[Ca2+]i signals, the number of neuronal [Ca
2+]i pks/s had a larger variance in all four conditions 
(figure 15): Pre-treatment (2.24 ± 1.10 x10-3 pks/s), CCH-GM (1.71 ± 0.63 x10-3 pks/s) , TTX  (2.14 
± 1.54 x10-3 pks/s) and GBZ (2.88 ± 1.78 x10-3 pks/s) ranging from 0 - 4.8 pks/s x10-3. Because of 
this large variance there was no significant difference in the mean number of [Ca2+]i pks/s in the 
pre-treatment time window compared to the CCH-GM condition or the other two conditions. 
This is unexpected since the acute wash-in of CCH, as aforementioned increases the [Ca2+]i 
activity in neurons. This effect however, was not found to last throughout the continued CCH 
wash-in and the onset of gamma oscillations, which was the time window that was included in 
this analysis. Likewise, it is surprising that the application of TTX did not significantly decrease 
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the neuronal [Ca2+]i activity. It has to be noted however, that the number of experiments with 
TTX and GBZ were lower (n = 4 and n = 3, respectively) compared to the number of CCH-GM 
experiments (n = 11), which has to be taken into consideration.  
 As the variance of the peak frequency especially in the neuronal [Ca2+]i peaks is rather 
large, the question arises whether the baseline [Ca2+]i activity in different experiments varies as 
well. Therefore, the difference in the number of pks/s before and after each treatment for each 
slice was analysed and is shown in figure 16. In all three conditions the treatment resulted in an 
increase in the number of astrocytic [Ca2+]i pks/s (figure 16 CCH-GM, TTX, GBZ). The same is true 
for the neuronal activity in TTX and GBZ treated slices, but not for the CCH-GM condition (figure 
16, CCH-GM).  
 
Figure 16: Changes in the number of [Ca
2+
]i peaks over time and ROI before and after treatment for each slice. For 
each pharmacological manipulation the number of peaks before the manipulation (Pre-treat.) and during the 
respective manipulation is shown for astrocytes (blue) and neurons (red). In the “Untreated” panel the first and the last 
minute of recordings without treatment are compared to each other.  
In 4 out of 11 experiments the number of [Ca2+]i pks/s increased during CCH-GM compared to 
the pre-treatment window, while in 7 experiments the number decreased. This is an interesting 
finding, since the CCH-GM seems to have no uniform effect on neuronal [Ca2+]i pks/s in different 
slices in contrast to the astrocytic [Ca2+]i which show remarkable uniformity in all conditions. It 
has to be noted though, that in those 7 experiments with decreased number of neuronal [Ca2+]i 
pks/s the activity was already much higher in the pre-treatment window compared to the 
activity pre-treatment with TTX and GBZ. This indicates that other methodological factors may 
account for variability in the number of neuronal [Ca2+]i pks/s.   
Since astrocytic [Ca2+]i pks/s increased very similarly in all four conditions, potentially the 
time the slices are in the imaging chamber itself could be the reason for this increase. In order to 
control for this, the [Ca2+]i pks/s of the first and the last minute of experiments with no 
treatment throughout the recording were compared. Results do not allow a clear conclusion 
since only two recordings without treatment were done. The number of astrocytic [Ca2+]i pks/s 
increased when comparing the first to the last minute of recording in one case, while in the 
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second case the number decreased. The range of these in- and decreasing numbers is similar to 
the range seen in all the treated conditions. In case of the neuronal [Ca2+]i pks/s in both 
untreated experiments the number increased and notably even the number of [Ca2+]i pks/s in the 
first minute was higher compared to the number of [Ca2+]i pks/s in all three treated conditions. 
Therefore, it can be concluded that the trends observed in the treated experiments are well 
within the range of the activity in the untreated conditions and are most likely not an effect of 
the pharmacological manipulations but are due to experimental variability. 
2.2.3 Changes in [Ca2+]i kinetics in astrocytes and neurons  
Even though the overall frequency of [Ca2+]i transients did not differ significantly, it is possible 
that [Ca2+]i kinetics in astrocytes or neurons are changed during oscillations. Therefore the [Ca
2+]i 
peak kinetics were analysed for the same conditions; pre-treatment, CCH-GM, TTX and GBZ. The 
slope ratio for 
each [Ca2+]i peak 
was calculated 
by dividing the 
absolute slope 
of the down 
stroke by the 
slope of the up 
stroke. Thus, a 
slope ratio close 
to 1 describes a 
symmetric peak, 
whereas values 
larger 1 indicate 
a slower decay 
time. Figure 17 
shows a boxplot 
of all astrocyte 
and neuron 
slope ratios for the four conditions. The median value for astrocytes in the pre-treatment 
condition was 1.9 and was almost the same as the CCH-GM condition (1.8), indicating in both 
cases that the rise of the [Ca2+]i signal was twice as fast as the decay and that this was 
independent from the CCH or CCH-GM treatment of the organotypic slice. The neuronal slope 
Figure 17: [Ca
2+
]i peaks shapes do not change during CCH-GM. Ratios were calculated by 
dividing the absolute value of the down stroke by the absolute value of the upstroke. Neither in 
astrocytic ROIs nor in neuronal ROIs the peak shape changed significantly in the four conditions: 
pre-treatment (Pre-t), CCH-GM, TTX and GBZ. Red line depicts the mean, coloured box is the 25th 
and the 75th percentile, whiskers depict most extreme values, not considered outliers. Outliers 
labelled as red cross.  
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ratios were quite similar to the astrocyte slope ratios with median values close to 2. Thus neither 
CCH nor CCH-GM had an impact on the [Ca2+]i kinetics in the astrocytes an neurons. 
Interestingly, both the astrocyte and the neuron slope ratio in the TTX experiments showed a 
trend towards a more symmetric peak shape (1.3 and 1.1, respectively) as well as in the 
astrocyte peaks in the GBZ condition. In all conditions the variance was very high and many 
peaks’ slope ratios are outliers resulting in large standard deviations (figure 17), which does not 
allow a clear conclusion from the peak analysis. Therefore it can be concluded, that the activity 
of the astrocyte population cannot be used as an indicator for different neuronal oscillatory 
states. 
2.2.4 Cross correlation of astrocytic and neuronal [Ca2+]i signals 
During gamma oscillations a single neuron was shown to participate in only about 5% of the 
cycles (Bartos et al., 2007). How neurons coordinate their participation in a cycle is not 
understood. Since the overall astrocytic [Ca2+]i activity does not globally increase or decrease 
during CCH-GM as shown above, the astrocytic [Ca2+]i transients potentially correlate temporally 
to the activity of single neurons on a local level, triggering or hampering selectively a neurons 
participation in the gamma oscillation. Therefore, the [Ca2+]i activity of both cell types was 
compared to each other in order to find patterns in the correlation between astrocytes and 
neurons. One measure of similarity of two time series is the normalized cross-correlation 
coefficient which is calculated as a function of the displacement or lag of two time series relative 
to each other. For each pair of astrocytic ROI and neuronal ROI in one recording the best 
correlation coefficient was determined for the lags of ± 100 frameshifts, which translates to ± 
15.7 s. The window size was selected large enough to theoretically fit 10 of the largest [Ca2+]i 
transients such as seen during GBZ wash in, but small enough to be biologically relevant, as it is 
unlikely that in in vitro preparations [Ca2+]i events that last maximum 2 s will have a plausible 
correlation to signals occurring minutes later. 
 Figure 18 shows the histogram of lags scoring the highest correlation coefficient of each 
astrocytic/neuronal ROI pair for the four conditions. If there was a tendency for astrocytic [Ca2+]i 
transients to occur after neuronal [Ca2+]i signals or just before neuronal [Ca
2+]i signals, the 
distribution of the lags would have a peak or an accumulation in the number of counts at the 
respective position. Except for the GBZ condition the lag distributions were quite similar and 
evenly distributed in all conditions. It has to be noted though, that the interpretation of the 
results from the untreated condition is difficult, since the number of untreated experiments is 
low compared to the other experiments. This is also problematic for comparison of the 
distribution of the cross correlation coefficients, since the histogram is comparably sparse.  
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For CCH-GM as well as TTX condition the lag was evenly distributed in the analysed time 
window, except for the 0-frame shift lag. While in the CCH-GM condition the 0-frame shift lag 
clearly stood out, this was not as prominent in the TTX condition, but it was still the most 
frequently observed lag.  
 
Figure 18: Maximum correlation coefficients of each astrocytic and neuronal ROI pair occur with evenly distributed 
lags during CCH-GM, and TTX treatment but show a pattern in GBZ experiments. The evenly distributed lags indicate 
that the best correlation coefficients occur randomly. Only in the GBZ experiments, a preference for certain periodical 
lags indicating temporal correlation of the astrocytic and neuronal ROIs.   
This observed lag distribution means that there was no uniform or preferred sequence of the 
occurrence of [Ca2+]i transients in astrocytic and neuronal ROIs. The comparably high number of 
counts in the 0-frame shift lag occurs due to signal sparsity and noise. In fluorescence traces with 
few peaks and some background noise, which affects astrocytic and neuronal traces (such as 
bleaching effects), the noise impacts the correlation coefficient stronger than the peak. 
Therefore, traces with few peaks will show the best correlation coefficient with 0 frame shifts to 
each other. This does not necessarily mean that astrocytes and neurons achieve a high 
correlation coefficient with 0 frame shifts, but that this was the best correlation coefficient the 
respective traces achieved. This becomes clear in the distribution of the cross-correlation 
coefficients (figure 19) which shows that the majority of coefficients in the TTX and the CCH-GM 
condition were below 0.5, indicating mostly low correlation in the investigated time window.  
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In the GBZ experiments the lag-distribution was not evenly distributed but had peaks at 
a few different lags (figure 18). These clusters appear somewhat periodically for lags of +5 
frames (0.8 s), +15 frames (2.3 s) and +25 frames (3.9 s) and not quite as prominent at + 35 
frames (5.5 s) as well as one large peak at -3 frames (0.47 s). In the GBZ experiments, as 
aforementioned the neuronal activity becomes synchronized and all the neurons fire together at 
the exact same time resulting in large peaks in the neuronal [Ca2+]i traces as shown in figure 14. 
These peaks last for about 1.57 s, which coincides with some of the intervals of the peaks in the 
lag distribution.  
 
Figure 19: Most correlation coefficients are found between 0.1 and 0.5, indicating low temporal correlation in each 
condition. Maximum of the correlation coefficients of each astrocytic ROI with each neuronal ROI for ± 100 frame 
shifts were calculated and showed overall low correlation coefficients. The distribution in CCH-GM showed a tail 
towards higher correlation coefficients. Also the GBZ correlation coefficient distribution shows a broad peak around 
0.5.  
Since the correlation coefficient is calculated as the scalar product of the (frame shifted) traces, 
the large neuronal peaks will result in high correlation coefficients whenever an astrocytic [Ca2+]i 
peak is shifted through them. Since all the neuron ROIs have the same peak at the same time, all 
astrocytic ROIs correlated to these synchronized neuronal ROIs will achieve a high correlation 
coefficient with exactly the same lag, resulting in the observed peaks in the lag distribution. 
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Thus, the patterns observed in the GBZ lag distribution occur due to the highly synchronous 
neuronal [Ca2+]i activity.  
This also affects the distribution of the correlation coefficients in the GBZ experiments. 
While the distribution was similar to TTX and CCH-GM in the range of 0 – 0.4, it had a small peak 
between 0.4 – 0.6 (figure 19), suggesting that GBZ increases the correlation between astrocytic 
and neuronal [Ca2+]i signals.  
 Most of the correlation coefficients in the untreated, CCH-GM and TTX were in the range 
of 0.2 – 0.4, which can be considered to be no or low correlation. In both the CCH-GM and TTX 
condition there was a small and broad peak in this range. CCH-GM however, also had a tail 
towards the higher correlation coefficients and even a small accumulation at 0.9, which was not 
the case in the TTX. This could mean that in the CCH-GM condition, more astrocytic/neuronal 
ROI pairs correlate over time compared to the TTX condition, when neuronal signal transduction 
is inhibited. While this is an interesting observation it could be owed to the fact, that CCH-GM 
includes more experiments than TTX and a larger number of TTX potentially would have resulted 
in the same tail.  
In order to check whether the observed distribution was the product of coincidence, the Ca2+ 
traces were shuffled. This way their temporal properties were disrupted. The correlation 
coefficient was calculated for the shuffled traces, again for a window of ± 15.7 s lag. In contrast 
to the real data, the distribution of correlation coefficients of the shuffled data is shifted closer 
to zero, indicating that the temporal disruption decreases the overall correlation (figure 20). 
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Figure 20: Distribution of correlation coefficients in shuffled datasets for each condition is similar to real data. Each 
astrocytic and neuronal ROI was shuffled 1000 times and the cross correlation coefficient was calculated as before. The 
resulting distribution reflects the original data set, indicating that the results can be the product of coincidence.  
Concluding from this, astrocytic and neuronal ROIs indeed have mild temporal correlation that 
differs from the correlation coefficients that is achieved by coincidence. Nonetheless, the 
distribution of the real data lies well within the range of the randomized distribution and was 
therefore not significantly different. This was most apparent for the aforementioned tailed 
distribution of CCH-GMs coefficient, with an accumulation at around 0.9, which was reproduced 
in the shuffled data set. This indicates that the CCH-GM data by chance scored these 
coefficients, independently from their temporal properties. Similarly, the distribution of the GBZ 
coefficients was reproduced in the shuffled data set. For the untreated condition the 
comparison between the real data and the shuffled data set was difficult since the shuffled data 
set, in contrast to the other conditions, is generated from only a single experiment, which most 
likely was the reason for the uneven distribution.  
Taken together, comparing astrocytic to neuronal ROI traces does not reveal a temporal 
sequence for the [Ca2+]i transients when the slice was untreated, during gamma oscillations or 
with inhibited neuronal signal transduction. Only when neurons were pushed towards a highly 
synchronous state as seen in the GBZ experiments, patterns in the lag coinciding with the global 
neuronal activity occurred. Overall, the correlation was low, and the observed higher 
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correlations coefficients occurred by coincidence as seen in the comparison to the shuffled data 
set.  
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3. Discussion 
3.1 Identification of astrocyte-neuron ensembles with eGFP-TTC  
In the presented study the eGFP-TTC tracer system was evaluated regarding its properties of 
“retrograde” uptake or its release from astrocytes. This is the first time eGFP-TTC fusion protein 
was expressed in astrocytes. The results have important implications regarding the 
controversially debated gliotransmission and reveal whether the virus transduced TTC-tracer 
system could be used as a tool to specifically target ensembles of astrocytes and neurons, as 
discussed below. 
3.1.1 Technical issues with virally delivered eGFP-TTC 
 Using an inducible transgenic mouse line (ALDH1/1-creERT2) exerting strict astrocytic 
expression, I showed that eGFP-TTC is not transferred from astrocytes to neurons. It was not 
possible to confirm this result with the two other approaches, the eGFP-TTC2A-KusO-construct 
as well as the combined eGFP-TTC mRNA and eGFP-TTC protein detection by FISH-IF assay due 
the KusO toxicity and the genomic DNA detection of the eGFP-TTC mRNA probe. For future 
experiments the 2A-KusO construct can be modified by using a different second reporter to 
avoid the observed toxicity. Another red-shifted reporter mScarlett has been reported to be 
non-toxic (Albakri et al., 2018) and might reliably label viable starter cells. Another potential 
problem in this approach is the gene configuration in the vector. In this study the KusO was 
linked via the 2A fragment at the 3’ end of the TTC sequence. After the cleavage of the 2A 
fragment during translation a residue stays behind at the C-terminus which may affect the 
synaptic translocation of the TTC fusion protein. Therefore, cleavage of the TTC and another 
stationary reporter should be analysed in western blot analysis or the TTC fusion should be 
placed in the 3’ postion of the polycistonic transcript.  
 In the FISH analysis the high copy number of rAAV infected genomes in the nucleus of 
the infected cells appeared as a major issue. Even strong DNAse treatment could not erase the 
viral DNA in the RNAscope® experiment. For neuronal rAAV tracer studies, where target cells lay 
in very distal brain regions, RNAscope® was applied successfully to distinguish neurons infected 
with rAAVs at their axon terminals (Reinert et.al 2019) from those being eGFP-positive through 
transsynaptical targeting by the eGFP-TTC protein. To analyse local transsynaptic tracing, a 5’ 
intron should be included in the rAAV encoded expression unit. This would allow to use a mRNA 
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specific expression probe which is composed of two neighbouring exonic sequence and thus is 
not able to bind efficiently to the genomic rAAV DNA. Alternatively, a lentiviral gene transfer 
system can be used, since lentivirus integrates with one or few copy in the host genome (Durand 
and Cimarelli, 2011).  
A general problem observed in all TTC experiments is the unspecific expression of rAAV 
delivered expression, using the “astrocyte specific” promoter GFAP. In case of the rAAV-GFAP-
eGFP, and therefore most likely for the rAAV-GFAP-eGFP-TTC, the unspecific expression of the 
vector was restricted to a subpopulation of neurons in the DG. One possible explanation for this 
phenomenon is neuronal progenitor cells (NPC) located in the DG. These cells are not yet fully 
differentiated and it is possible that these cells have a low baseline expression of GFAP driven 
constructs (Freeman, 2010). This issue is specific to this region and is not observed in the 
pyramidal cell layer of the CA region. Results from rAAV approaches in the DG therefore have to 
be interpreted accordingly. Interestingly, the same promoter was used in the construct 
expressing Ca2+ indicator GCaMP for Ca2+ imaging experiments and no non-specific expression in 
hippocampal neurons was observed in this case (data not shown). However, these studies 
focussed on the CA region and potential weak expression in the DG may have been overlooked.  
 The leaky expression of the cre-dependent rAAV-GFAP-eGFP-TTC-DIO construct was very 
sparse and restricted to an undefined cell type outside of the DG. It remains to be resolved why 
these cells express the construct without prior to cre-recombinase activation. In the available 
literature, a cre-independent, leaky expression of the eGFP-TTC-DIO expression unit was not yet 
described. Depending on the application, the cre-independent expression of the construct can 
be neglected in many experiments. However, in the presented experiments the non-specific 
expression of the eGFP-TTC in neurons can lead to false positive results due to the putative 
translocation of eGFP-TTC to synaptically linked neurons. Interestingly, that was not the case in 
the ALDH1/1 mice experiment. This suggests that the cells, expressing the DIO construct in the 
absence of cre-recombinase, are not neurons. Nonetheless, the cre-independent expression of 
rAAV-GFAP-eGFP-TTC-DIO is as aforementioned not reported in the literature and has to be 
considered in experimental designs and the interpretation of results. 
 
 
3.1.2 Transport from and to astrocytes 
The comparison of the eGFP positive hippocampal area in ALDH1-Cre-ERT2/rAAV-GFAP-eGFP-
TTC-DIO and rAAV-GFAP-eGFP-TCC, suggested that eGFP-TTC could be transported from one 
astrocyte to another. One possible explanation could be that the TTC fragment facilitates 
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transport from ALDH1 positive astrocyte to other astrocytes possibly at locations where only 
astrocytes form a sort of interface where there is no accessible neuronal process close by. As 
described astrocytes form gap-junctions with each other. While the gap-junction channels are 
too small for transport of large proteins such as eGFP-TTC, the formation of them results in 
effectively clamping the cell membranes of two cells together, with a tight gap of 2 – 4 nm 
between them (Fushiki et al., 2010). One could hypothesise, that the TTC retrograde transport 
requires close proximity of two cell membranes to manage the intercellular leap. In case of 
neurons, the synaptic cleft is exploited and in case of astrocytes potentially gap-junctions could 
facilitate this requirement.    
 Other possible explanation for the differential spread of the eGFP-TTC protein, could be 
the viral particles themselves. The spread of rAAV particles has been previously investigated and 
rAAV are known to travel distances of up to 1 mm (Reinert 2012). Other reports even claim 
anterograde transport of virus particles along axonal fibres (Zingg et al., 2017). How and why 
exactly rAAVs are transported is not conclusively explained and again the question arises, why 
eGFP does not spread as far as eGFP-TTC, since both reporters are rAAV delivered and should 
therefore be transported in similar ways. Another factor could be experimental variability of the 
injection process, such as injection speed and variations in the injected volume. Therefore, it 
remains to be elucidated if the spread is a TTC-dependent effect or a rAAV and/or 
methodological effect.  
  
3.1.3 Implications on gliotransmission 
The TTC tracer experiment suggests, that despite astrocytes being the third partner at the 
tripartite synapse, the molecular structures exploited by TTC to leave and re-enter cells 
retrogradely, are not present on astrocytes. Due to the discussed methodological issues the 
potential transfer between astrocytes could not be experimentally investigated. However, since 
experiments with neuronal eGFP-TTC expression do not show any eGFP positive astrocytes it is 
questionable if eGFP-TTC can enter these cells. This is surprising given the undisputed presence 
of astrocytic processes in close proximity to synapses (Araque et al., 1999). Therefore, one would 
expect that astrocytes could receive the TTC as off-target effect. However, this is not the case 
and suggests that the target structures for TTC are not present on the cell membrane of 
astrocytes. While this has to be confirmed in more detail, it has implications regarding the 
gliotransmission controversy. Vesicular release from astrocytes (Schwarz et al., 2017) similar to 
neurotransmitter release utilizing similar molecular machinery has been described and is one of 
the main arguments for the existence of gliotransmission. If TTC was able to also enter 
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astrocytes when it is expressed in neurons, this would have been a strong indication for the 
existence of gliotransmission. The finding that eGFP-TTC does not enter astrocytes, however 
does not lead to the conclusion that gliotransmission does not exist, as there are many possible 
explanations as to why the transfer does not take place. The full target structures recognized by 
TTC are not known, but it is possible that they do not exist in astrocytes. Another issue could be 
the spatial proximity. Despite astrocytic processes being positioned close to synapses, the 
synaptic cleft spanning 20 nm is a very tight construct and bridged by interactions of membrane 
proteins in the pre- and postsynapse, like neurolegins and neuroexins (Craig and Kang, 2007). As 
suggested before close proximity of two adjacent cell membranes could be a possible 
requirement for the TTC transport. As consequence eGFP-TTC cannot be used as tool to identify 
astrocyte-neuron interactions. However, other retrograde tracers may still yield the potential to 
achieve this goal. One example is the rabies tracer system, which exploits the retrograde 
properties of the rabies virus particles itself (Schnell et al., 2010). Similar to TeNT it infects axon 
terminals in the periphery and is then transported retrogradely into the central nervous system. 
It replicates in cell bodies and is then transferred via synapses into higher order neurons. To use 
rabies as a monosynaptic tracer tool it has been modified by deleting the gene essential for 
packing and transsynaptically spreading of the virus particles (Mazarakis et al., 2001). This traps 
the virus in its primary infected cell. By providing the rabies glycoprotein specifically in the cells 
of the “starter region” the otherwise glycoprotein deficient rabies vector is packaged and can 
“jump” across one synapse into the next higher order neurons.The virus is then trapped in the 
target cell because the target cell cannot provide the rabies glycoprotein (Wickersham et al., 
2009). This system equipped with fluorescent reporters was exploited for many tracer studies 
elucidating the neuronal connectome (Callaway, 2005; Haberl et al., 2015; Osakda et al., 2012; 
Rancz et al., 2011; Schwarz et al., 2015). The exact mechanism of retrograde infection is also not 
fully understood (Ginger et al., 2013). Nonetheless, several neuronal tracer experiments 
“unexpectedly resulted in the labelling of astrocytes” (Deshpande et al., 2013). Thus in contrast 
to TTC, the uptake mechanism of the rabies virus seems to work to a certain degree to visualize 
astrocyte – neuron interactions and might potentially be used for selective labelling of astrocyte-
neuron ensembles.  
3.2 [Ca2+]i activity during gamma oscillations 
Besides elucidating the astrocyte to neuron connectivity with the genetically encoded tracer 
system, the second part of the presented study investigated the physiological interactions of 
hippocampal astrocytes and neurons. The astrocytic as well as neuronal [Ca2+]i activity during 
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gamma oscillations and how the two cell populations’ activities correlate to each other was 
analysed in organotypic cultures. Results clearly show, that astrocytic and neuronal [Ca2+]i 
activity is not significantly altered by CCH-GM. Moreover, astrocytes and neurons do not show 
any specific activity pattern during gamma oscillations indicating that neither in astrocytes nor in 
neurons can the [Ca2+]i activity pattern be used to predict the oscillatory activity and thus basal 
state of a brain. 
 
3.2.1 Spatial Characteristics: Population stability 
While the temporal aspects of [Ca2+]i activity were the main focus of this study, the [Ca
2+]i-ROIs 
spatial distribution between consecutive recordings was compared. By comparing the [Ca2+]i 
activity of two different but subsequent recordings from the same hippocampal organotypic 
slice, I found that astrocytic ROIs were less stable from one recording to the other compared to 
neuronal ROIs.  
One important aspect in this analysis is the ROI detection. Since this is the first step in 
the analysis, false detection or missing of ROIs impacts the following analysis results. The applied 
CNMF method is one out of numerous automated segmentation approaches (Agarwal et al., 
2017; Poskanzer and Molofsky, 2018; Srinivasan et al., 2015). The selected method delivered 
results in accordance to manual test selection of ROIs, however tended to false positively detect 
ROIs. To take account for this, a manual validation step was included. Therefore, the presented 
image processing results have been controlled to the best of knowledge, but it is nonetheless 
possible that different approaches would have delivered different ROIs. Especially, for the spatial 
analysis this is a potential source for biased results. However, it was possible in case of the 
neuronal ROIs to detected them a second time in the second recording. Therefore, the reason 
that the majority of astrocytes could not be re-detected does not lie in the ROI detection and the 
population stability experiments can be regarded as an internal control for the automated 
segmentation.  
Another aspect to consider in the interpretation of spatial distribution results is that in 
the respective two consecutive recordings, different pharmacological manipulations were 
applied. Since the spatial comparison of ROIs was not the focus of the presented study, the n-
numbers of the applied pharmancons are too low for statistical analysis. No similar analysis has 
been done before, thus it would be interesting to further investigate whether different 
pharmacological agents have different impacts on the ROI stability. From the presented results it 
can be concluded already that the two cell populations react differently. While the active neuron 
population remains stable the astrocyte population appears unstable. The astrocytic population 
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instability is most likely a property inherent to astrocytes that occurs independently from 
external manipulations. This conclusion is accordance to the other results in this work, that 
indicate that astrocytic [Ca2+]i transient properties, such as frequency and peak shape, are not 
affected by external manipulations, gamma oscillations or neuronal [Ca2+]i transients.  
 
3.2.2 Temporal characteristics: [Ca2+]i peaks  
The analysis of the number of peaks in the relative fluorescence intensity showed in all 
conditions for astrocytes comparably low numbers ranging between 0 and 0.002 pks/s per ROI. 
To put this number into perspective, the maximum pks/s observed in astrocytes is 0.002 pks/s 
which means if there was only a single ROI in this respective recording, it would show a peak 
every 500s (approximately 8.3 min). This is not an unusual finding as spontaneous astrocytic 
[Ca2+]i activity has been reported to be sparse in vivo and in vitro if not externally stimulated 
(Tang et al. 2015). It has to be noted however, that definition of a peak in the relative 
fluorescence intensity depends on applying a threshold. In this study the threshold for peak 
detection allowed the detection of only high and prominent peaks. Applying, a less stringent 
threshold would potentially increase the number of peaks at the cost of false positive detection. 
Peak detection in noisy data is a problem found throughout literature (Prada et al., 2018) and 
different methods exist to solve this issue but result in different biases. This has to be considered 
in the interpretation of the data. In the presented study only high and prominent peaks were 
considered and these did not show a change in frequency upon CCH-GM, TTX or GBZ. I cannot 
conclude that smaller peaks, that potentially come from smaller [Ca2+]i transients behave in a 
similar way, since the applied method did not detect the smaller [Ca2+]i transients. 
 The same is true for the analysed slope ratio. Results of the slope ratios, similarly to the 
peak frequency, show no significant change in the astrocytic and the neuronal [Ca2+]i transients. 
In all four conditions the variability of the slope ratios is quite high. Nonetheless, the slope ratios 
of astrocytic [Ca2+]i transients measured in the TTX and GBZ experiments trend towards a more 
symmetric peak shape. This is interesting since the two drugs have different targets and 
opposing effects. In case of TTX this means that hampering neurotransmission could have an 
impact on astrocytic [Ca2+]i, namely rendering astrocytic [Ca
2+]i transients decay time shorter. 
Since astrocytes do not express the voltage dependent sodium channels targeted by TTX 
(Verkhratsky and Nedergaard, 2017), this effect can only occur due to the lack of neuronal input. 
In case of the GBZ experiments neurotransmission is effectively increasing as inhibitory input is 
blocked. However, astrocytes are known to express GABAA receptors, thus a direct effect of GBZ 
on astrocytes cannot be excluded (Bekar and Walz, 1999).  
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In conclusion, the analysed properties of the peaks in the relative fluorescence of the Ca2+ 
indicators are independent from the pharmacological manipulations as well as from CCH-GM. 
 
3.2.3 Interactions of astrocytes and neurons during gamma oscillations  
It is known that gamma oscillations in the brain are important for cognitive processes as well as 
memory and learning (Bartos et al., 2007; Buzsaki and Draguhn, 2004). Despite numerous 
studies elucidating the cellular underpinnings of these oscillations it is unknown how exactly 
they occur in vivo as well as in slice preparations. Most studies investigating this however, never 
considered that astrocytes potentially contribute to this process and the models development 
for the gamma oscillations circuit are solely based on neuronal signalling. 
 Lee et al. investigated for the first time how astrocytic [Ca2+]i elevations are linked to 
gamma oscillations and found that they precede the onset of the oscillations (Lee et al., 2014). 
The here presented study cannot confirm this result, since the acute wash-in phase of CCH was 
not included in the analysis. These time windows were excluded as it is known that CCH induces 
immediate response [Ca2+]i transients in astrocytes. These occur due to direct stimulation of 
AChRs expressed by astrocytes (Shelton and Mccarthy, 2000), which is why in the presented 
study also TTX was washed in together with CCH as control condition. Indeed, in the initial phase 
of the CCH wash-in, an immediate astrocytic [Ca2+]i increased was observed for a very short time. 
Since Lee et al., used the chemical Ca2+ indicator fura-2, a Ca2+ indicator with much lower signal 
rise and decay time, potentially the direct CCH effect on astrocytes was misinterpreted as an 
astrocytic [Ca2+]i elevations preceding the onset of gamma oscillations (Lee et al., 2014). 
 Nonetheless, Lee et al. could show, that [Ca2+]i dependent vesicular release of 
transmitters is required for the maintenance of CCH-GM, since genetically blocking vesicular 
release from astrocytes decreased the gamma oscillation duration (Lee et al., 2014). While the 
direct interactions from astrocytic [Ca2+]i transients and neuronal activity remain unclear in their 
study, it suggests that astrocytic [Ca2+]i transients precede neuronal [Ca
2+]i transients, since the 
[Ca2+]i-dependent glutamate release from astrocytes lower the threshold for APs. This was 
investigated in the presented work by cross-correlating the astrocytic and neuronal [Ca2+]i 
transients during CCH-GM. Results showed that astrocytic [Ca2+]i and neuronal [Ca
2+]i transients 
do not follow a specific sequence or have a strong temporal correlation overall.  
 The cross-correlation is a good measure to find out whether two time series repeatedly 
act together or in a specific sequence relative to each other. The comparably low cross-
correlation coefficients either mean that astrocytic [Ca2+]i and neuronal [Ca
2+]i transients do not 
correlate, or that the correlations are more subtle. As the cross correlation always compares all 
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time points of a respective time series with another time series, sparse correlations could be 
overlooked. If for example each neuronal transient is preceded by an astrocytic [Ca2+]i transient, 
but not all astrocytic [Ca2+]i signals are followed by a neuronal event, the cross correlation would 
not detect this peak-wise correlation. The coefficient would indicate no correlation while some, 
but not all astrocytic [Ca2+]i peaks show a similar pattern in their occurrence.  
 A way to work around this would be to isolate neuronal and astrocytic events with a 
feasible time window around it. A similar analysis was performed by Poskanzer and Yuste when 
analysing cortical state switches (Poskanzer and Yuste, 2016). However, this again relies on peak 
extraction, which as discussed, biases the results.  
Future investigations need to refine analysis tools to potentially reveal a correlation of a 
certain subpopulation of astrocytic [Ca2+]i events with neuronal [Ca
2+]i events. Such an approach 
would require classifying [Ca2+]i events in astrocytes and/or identify potential subpopulations. It 
is known that [Ca2+]i transients are triggered through different pathways and so far, [Ca
2+]i 
transients are mostly classified according to their size and position in the cell such as soma or 
micro domain (Agarwal et al., 2017; Shigetomi et al., 2013). In the presented study it was not 
possible to discriminate the subcellular structures due to limitations in the imaging resolution, 
since an epifluorescence microscope was used. Thus, the here observed [Ca2+]i events are most 
likely a mix of differently triggered [Ca2+]i transients. Potentially existing patterns or correlations 
in only a subset of the [Ca2+]i events could therefore be masked. Ideally, other molecular factors, 
that discriminate [Ca2+]i signals from other [Ca
2+]i signals should be used for a better 
understanding of the function and interaction of [Ca2+]i transients in astrocytes. Moreover, could 
multiphoton approaches help to better resolve the spatial distribution also in the z-plane and 
therefore allow the distinction of different microdomains.    
In conclusion, with the given methods I was not able to detect direct effects or correlations of 
astrocytic [Ca2+]i signals during gamma oscillations. This can either mean that these correlations 
indeed do not exist, or the applied methods are not suited to distinguish subtle changes in the 
activity. While Lee et al make a strong case for astrocytic involvement during gamma oscillations 
(Lee et al., 2014), especially in vivo, from my in vitro studies I cannot confirm that [Ca2+]i 
transients in astrocytes are involved or affected by CCH-induced gamma oscillations. 
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4. Methods 
 
4.1. Molecular biological methods  
All standard methods for plasmid cloning, transformation of competent E.coli bacteria cultures 
and PCR techniques were adapted from Howland, 1996 and are described in brief below:  
 
4.1.1 PCR 
DNA templates (100 ng) were each amplified by Phusion high-fidelity DNA polymerase (NEB, 
Frankfurt) 2 U/µL in 20 µl reaction volume supplied with respective flanking forward and reverse 
primers 10 µM each, 10 mM dNTPs, and Phusion reaction buffer. Amplification was achieved 
with 35 cycles of denaturation at 98° C for 10 s, annealing at 60° C for 30 s, extension at 75° C for 
30 s/1kbp and a single final extension cycle at 60° C for 5 min in the ABI 7500 cycler (Applied 
Biosystems, Foster City, CA, USA).  
 
4.1.2 DNA restriction, electrophoresis and gel purification  
All DNA restriction enzymes were obtained from NewEngland Biolabs (Ipswich, Massachusetts, 
USA). DNA restriction for either qualitative check of purified plasmid or preparative digest for 
cloning was performed with 1 U of respective restriction enzyme per 1 µg of DNA in restriction 
buffer. Restriction conditions were kept according to manufacturer's instructions. Restriction 
reaction was stopped by heat inactivation at 65° C when necessary and results were checked by 
agarose gel electrophoresis. 1-2% (w/v) agarose were brought in solution in TAE buffer (20 mM 
Tris, 10 mM Sodium acetate, 0.5 mM EDTA, pH 7.8) and 0.5 µg/ml EtBr were added for 
visualization of DNA bands. DNA fragments were separated by electrophoresis at 150 V for 35 
min. lambda-DNA (Fermentas/Thermo Fisher Scientific) digested with Sty-1 was used as size 
marker. DNA bands were visualized on transilluminator.   
For gel extraction of DNA from preparative gels, respective bands-containing gel regions were 
carefully cut out and DNA was purified with the zymoclean gel DNA recovery kit (zymo research, 
Freiburg, Germany) according to the manufacturer's instructions. In brief, the DNA containing 
gel is melted and washed over anion-exchange column and DNA is eluted with 30 µl elution 
buffer. 
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4.1.3 Ligation 
For cloning of rAAV constructs, inserts amplified with PCR were joined in rAAV backbone by 
ligation. The linear DNA fragments with compatible sticky ends were joined under ATP 
consumption with T4 DNA ligase (Roche, Penzberg) in 20 µl volume containing the ligase, ATP 
and reaction buffer. Backbone and insert were supplied in different molar ratios and 1 U of T4 
ligase per 1 pM DNA was added. Ligation mix was incubated for 2 hrs at RT.    
 
4.1.4 Plasmid amplification: Transformation and plasmid purification 
from E.coli 
rAAV- vector plasmids were transformed into SURE competent E.coli (Stratagene, California). 
100 µl of competent cells at a density of 1x108 were thawed on ice and 1 µg of the plasmid DNA 
was added to the cells and incubated for 20 min on ice. Cells were then heat-shocked for 30 s at 
42° C and immediately placed on ice again for 2 min. 300 µl of pre-warmed LB medium (10 g/l 
Bacto Trypton, 5 g/l Bacto Yeast Extract, 10 g/l NaCl, 4 mM MgSO4, 10 mM KCl, pH 7.6 (KOH)) 
were added. Cells were then incubated for 1 hr at 37° C before the bacteria suspension was 
plated on LB-agar plates (15 g/l Agar, 5 g/l Bacto Yeast Extract, 10 g/l NaCl, 4 mM MgSO4, 10 
mM KCl, pH 7.6 (KOH)) containing 0.2 mg/mL ampicillin (Sigma-Aldrich, Steinheim) and 
incubated overnight at 37° C. Colonies were picked and grown in 2 ml starter culture LB-medium 
with ampicillin (Merck KGaA, Darmstadt, Germany) for 12 hrs at 37° C and 200 µl were used for 
inoculation of 200 mL TB medium (12 g/l tryptone, 24 g/l yeast extract, 4 ml/l glycerol, 0.17 M 
KH2PO4, 0.72 M K2HPO4) with ampicillin for overnight culture at 37° C.   
Plasmids were purified from E.coli using HiSpeed Plasmid Maxi Kit (Quiagen, Venlo, Netherlands) 
according to the manufacturer's instructions. In brief, bacteria were pelleted at 6000 x g for 15 
min at 4° C. Cells were resuspended and lysed for 5 min and subsequently neutralized. Insoluble 
protein phase was fractionated by centrifugation at 6000 x g for 30 min at 4° C. Supernatant was 
filtered and allowed to run over the HiSpeed Plasmid Maxi Kit column by gravity flow. After 
washing the column plasmid DNA was eluted with 500 µl ultra-pure water.  
 
4.1.5 Cloning of rAAV vectors  
pAAV-Syn-eGFP-TTC was kindly provided from Prof. Dr. Thomas Kuner. The pAAV-GFAP-eGFP-
TTC was produced by isolating the eGFP-TTC fragment from the syn-eGFP-TTC construct using 
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XbaI and SalI restriction enzymes. The isolated 2786 bp eGFP-TTC fragment was inserted into 
GFAP-tdTomato backbone where the td-Tomato fragment had been excised with NehI and SalI, 
by sticky end ligation.  
The pAAV-GFAP-eGFP-TTC-2A-KO plasmid was cloned by fusion PCR. The 2A-KO fragment from 
the pAAV-syn-tTa-2A-KusO (obtained from R. Sprengel) plasmid was amplified with custom 
made primers  flanking the 2A-KusO including two flanking restriction sites (NotI and XhoI) on 
each end. (Primers1.   5’CCACCCGCAGTTCGAAAAACTCGAGGGCAGAGGAAGTCTTCTAA 
CATGC3’, Primer 2: 5’GAT-AAGCTTGCGGCCGCTTTACTTGTACA 3’). Primer 1 is designed to 
be half complement of the 5’ end of the TTC-coding region of the GFAP-eGFP-TTC 
plasmid. Similarly the 5’ end of the TTC-coding region from the GFAP-eGFP-TTC coding plasmid 
including two flanking restriction site (EcoRI and NotI) was amplified (Primer 3: 
5’AATCTTGATAGAATTCTAAGAGTA3’, primer 4: 5’ TCTGCCCTCGAGTTTTTCGAACT 
GCGGGTGGCTCCAC3’). The two amplified fragments were fused in a fusion PCR reaction with 
primers 1,3 and 4  as described in (Yon and Fried, 1989). The PCR product contains the fusion of 
the two fragments which was then digested with EcoRI to produce a sticky end. Likewise, the 
GFAP-eGFP-TTC plasmid was digested with EcoRI and NotI for sticky end ligation.  
pAAV-GFAP-eGFP-TTC-DIO was kindly cloned by Michaela Kaiser. In brief, the GFAP promotor 
was PCR- amplified from the pAAV-GFAP-tdTomato (primer forward: 
TTTGGTACCAAGATCTAACAT-ATCCTGGTGTGGAGTAGGGGACGC, primer reverse: 
TTTCGAATTCTCGAGTCTAGAGCTAGCCTATAGTG AGTCGTATTAAGTAC) and subcloned into a 
cloning vector containing the MCS flanked by DIO recognition sites, using KpnI and EcoRI 
restriction sites. The eGFP-TTC fragment was isolated from the pAAV-Syn-eGFP-TTC with 
XbaI/NheI digestion and subcloned into the MCS of the DIO-containing construct.  
All ligation and transformation was performed as described above. All plasmids were sequenced 
after cloning with GATC service. pAAV-GFAP-eGFP, pAAV-GFAP-GcaMP6f and pAAV-GFAP-
tdTomato were obtained from addgene (eGFP: Cat#50473,https://www.addgene.org/50473/, 
GcaMP6: Cat#52925, https://www.addgene.org/52925/, tomato: Cat#44332 
https://www.addgene.org/44332/). 
 
4.1.6. Virus production: transfection of HEK293 and rAAV purification   
Cell culture maintenance for virus production was kindly performed by Annette Herold. HEK293 
cells were cultured in MEM, 5% or 10% FCS, 100 U/ml Penicillin/Streptomycin, 2 mM L-
glutamine. Recombinant AAV (rAAV) vectors were produced in HEK293 cells, co-transfected with 
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helper plasmids encoding the rep and cap genes of serotype 1 and 2 adenovirus (pH21), 
adenoviral helper genes (pF6Δ) and the respective expression construct, as described in During 
et al., 2003.  
HEK293 cells were plated in 10 cm cell culture dishes at a density of 4 x 106 cells per dish and 
allowed to reach 50-60% confluence overnight. A total of 20 ng of plasmid mix was calcium-
phosphate transfected and cells were stored at 37° C, 3% CO2 atmosphere. 60 hrs post 
transfection cells and supernatant was harvested and pelleted (3000 x g, 10 min). Supernatant 
was decanted and stored on ice for later virus purification, while the pellet was resuspended in 
TNT buffer (20 mM Tris, 150 mM NaCl, 1% TritonX-100, 10 mM MgCl2, pH 7.5) and incubated for 
10 min at RT. 4 U/ml benzonase (Sigma-Aldrich, Steinheim) is added and incubated 1 hrs at 37° 
C. Supernatant and cell lysate are centrifuged for 10 min at 3000 x g and subsequently sterile 
filtered with 22 µm pore size filter to separate insoluble material. Virus purification was achieved 
by affinity chromatography using the ÄKTA prime plus system (GE Healthcare, Europe GmbH) in 
combination with a HiTrap sepharose column (1 ml HiTrap AVB Sepharose HP column, GE 
Healthcare GmbH). The column was equilibrated with 10 ml PBS (10 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4x2H2O, 1.8 mM KH2PO4) at 0.5 ml/min before virus-containing cell lysate and 
supernatant was pumped through the column at 2 ml/min to allow virus particles to bind to it. 
Virus particles were eluted with 50 mM glycine at pH 2.7 at a flow rate of 1 ml/min and collected 
in 1 ml fractions and neutralized with Tris-HCl pH 8.0. Fractions containing eluted virus were 
identified by the peak in UV absorbance. Respective fractions were washed three times in 4 ml 
sterile PBS and concentrated in cellulose concentrator tubes (Amicon Ultra tubes, Merck 
Millipore, Darmstadt, Germany) by spinning at 3000 x g for 4 min. Purified and concentrated 
virus was again sterile filtered (Acrodisc, Renner, Dannstadt-Schauernheim, Germany) and 
stored at -80° C until used. 
 
4.1.7. Hippocampal slice cultures 
Hippocampal slice cultures were prepared from 8-days-old rats. Animals were decapitated and 
their heads quickly placed in ice-cold dissection buffer (10 mM MgCl2, Merck; 20 mM HEPES in 
Ringer solution; pH 7.2)). Brains were quickly removed and while constantly kept in ice-cold 
dissection buffer the hippocampus was separated hemisphere-wise. Isolated hippocampi were 
cut into 350 µm thick slices with a tissue chopper (Campden Instruments Ltd., England). Slices 
were carefully placed on cell culture plate inlets (PicM0REG50, MerckMillipore, Darmstadt, 
Germany) and cultured in 6-well-plates with 1 ml hippocampal slice medium (50% MEM; 25% 
EBSS ; 25% horse serum , 2% B27, 2% Glucose ( 32% in MEM)). Slices were maintained at 37° C at 
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5% CO2. Every 3 days 50% of medium was exchanged. Hippocampal slice preparation was kindly 
carried out by Andrea Lewen. Slice cultures were infected with Ca2+ -indicator-expressing rAAVs 
at day 3 post preparation by placing 0.2 µl droplets of viral solution on the slice. Slices were used 
for imaging earliest on day 10 post infection.  
4.2. Animals 
4.2.1 Legal aspects 
All animal handling and experimental procedures were performed according to the animal 
welfare guidelines of the Max Planck Society. Animal experiments were performed under the 
license at the Regierungspräsidium Karlsruhe G-100/15 and G-32/18. 
 
4.2.2 Housing 
Mice were housed individually or in pairs of two in Makrolon type II cages in an on-site animal 
facility. The facility is kept at a 12hrs/12hrs light/dark circle with the light phase starting at 7 am. 
Temperature is kept at 23-24° C and at a humidity of 56%. Animals had access to food and water 
ad libitum throughout the experiments. All procedures were performed during the light phase.  
 
4.2.3 Stereotaxic rAAV delivery 
For stereotactic injections animals were anesthetized either by isoflurane (Baxter, 
Unterschleiheim,Germany) inhalation (2% for anaesthesia initiation and 1.5% during operation) 
or by i.p. injection of anaesthesia mix consisting of Fentanyl (0,24 mg/kg body weight), 
Midazolam (0.93 mg/kg body weight) and Medetomidin (0,715 mg/kg body weight). Anaesthesia 
was monitored by testing pain reflexes before placing animals in the stereotactic frame and 
throughout the operation. Animals were placed in the stereotactic frame (David Kopf 
Instruments, Tujunga, CA USA) and eyes were covered with ointment (Bepanthene, Bayer, 
Leverkusen, Germany) to prevent damage. After exposing the skull its position was adjusted to 
level the hemispheres in all spatial dimensions using the digital display console. For Injections 
into the CA1 region of the hippocampus and cortex the following coordinates relative to bregma 
were used: HPC: anteroposterior (AP) -2.18 mm; mediolateral (ML) ± 1.5 mm; dorso-ventral (DV) 
from pial surface -1.2 mm for CA1, -0.45 for cortex. At the marked coordinates a small 
craniotomy was made using a dental drill (Osada Electronic, Los Angeles, CA, USA). A glass 
injection micropipette (inner diameter 9 µm, Blaubrand intraMark, Wertheim, Germany) was 
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filled with viral solution by applying negative pressure to the pipette using a syringe. At the 
respective injection sites a total volume of 100 nl was injected at a rate of approximately 30 
nl/min. After 3 min post injection the micropipette was retracted, the scalp sutured. The 
anaesthesia was antagonized with an antidote mix of Atipamezol (1.898 mg/kg body weight), 
Flumazenil (0,506 mg/kg body weight) and Naloxon (0,304 mg/kg body weight). Animals were 
placed in their home cage on a heating plate to prevent hypothermia. On the days following 
operation animals were treated with Carprofen (5 mg/kg body weight) to reduce pain.     
 
4.2.4 Perfusion  
 
Perfusion was performed on anesthetized animals. Animals were injected with pentobarbital 
(“Narcoren”, Janssen-Cilag GmbH, Neuss, Germany) at 500 mg/kg body weight and as soon as 
pain reflexes were absent the heart was exposed by thoracotomy. Animals were transcardially 
perfused through the left ventricle with 25 ml PBS followed by 25 ml of 4% PFA in PBS. The brain 
was removed from the skull and placed in 4% PFA at 4° C overnight for post fixation and washed 
and stored in PBS until further processing. Brains for RNAscope® assays were placed in 15% 
sucrose in PBS for 24 hrs and 30% sucrose for another 24 hrs before they were frozen into 
cryomold for cryosectioning.    
 
4.2.5 Cryosections 
For RNAscope® assay brains were embedded in cryo embedding medium (Jung, Leica 
Microsystems, Nussloch, Germany) and stored at -80° C until they were sliced. For slicing the 
cryotome (Leica, Wetzlar, Germany) was set to -22° C and the embedded brain was stored in the 
cryotome for 60 min prior slicing for temperature equilibration. Slices were cut at 20 µm 
thickness and stored free-floating in anti-freeze (25% Glycerol, 30% Ethylene glycol, 50 mM PBS) 
solution at -20° C. 
 
4.2.6 Vibratome sections 
For immunohistochemistry PFA-fixed brains were sliced coronal or horizontal at 70 µm thickness 
using a vibratome (Leica, Wetzlar, Germany). Sections were collected and stored free-floating in 
PBS for short term storage. For long-term storage slices were placed in anti-freeze solution and 
stored at -20° C.  
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4.3. Histological Assays 
4.3.1 Immunofluorescence assays 
For immunofluorescence assays slices were placed in 24-well plates free floating in PBS. All 
incubation steps were performed gently shaking. Slices were blocked for 2 hrs at RT in blocking 
buffer (5% normal goat serum, 0.5% TritonX-100, 1% bovine serum albumin in PBS) followed by 
5 min wash in 0.5% TritonX-100 in PBS. Primary antibodies were applied according to table 1 in 
0.5% TritonX-100, and 1% BSA in PBS at 4° C. Slices were washed 3 x 10 min in 0.5% TritonX-100 
in PBS before fluorophore conjugated secondary antibody (dilutions specified in table 2) was 
applied and incubated for 2 hrs at RT. Slices were washed in PBS 2 x 10 min at RT and 
counterstained with DAPI diluted 1:10000 in PBS for 15 min at RT. After final wash in PBS slices 
were mounted on glass slides (Menzel-Gläser, Braunschweig , Germany), air dried for 10 min and 
embedded in aqua polymount (Polyscience, Warrington,USA).  
 
Table 1: Primary antibodies 
 
Table 2: Fluorophore conjugated secondary antibodies 
Secondary antibody Species  Dilution Manufacturer Cat# Lot# 
Cy3-conjugated α-chicken donkey  1:400 Jackson Immuno 
Research 
703-165-
155 
12043
1 
Cy3-conjugated α-mouse Goat  1:400 Jackson Immuno 
Research 
115-165-
003 
13463
5 
Cy3-conjugated α-rabbit goat 1:400 Jackson Immuno 
Research 
111-165-
144 
10395
3 
FITC-conjugated α-
chicken 
donkey  1:400 Jackson Immuno 
Research 
703-545-
155 
12349
6 
FITC-conjugated α-rabbit Goat 1:200 Jackson Immuno 
Research 
111-095-
144 
94765 
 
Primary antibody Species  Dilution Manufacturer Cat# Lot# 
GFP chicken 1:1000 Abcam ab13970 236651-25 
NeuN mouse 1:1000 Merck clone A60 2987527 
GFAP chicken 1:1000 Biolegend PCK-591P Poly28294 
GFP rabbit 1:1000 Abcam ab 6556 GR249192-1 
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4.3.2 In situ hybridization RNAscope® and Immunofluorescence  
RNAscope® assay was performed according to manufacturer’s instructions with all solutions 
provided in RNAscope®2.5 HD Reagent Kit-RED (Advanced cell diagnostics Inc., Newark, 
California, USA). Cryosections were carefully washed in 50% EtOH and mounted on Superfrost 
glass slides (Thermo Fisher Scientific) and dried on a heat plate at 37° C for 30 min.  Slices were 
then dehydrated with 70% EtOH for 5 min and 100% EtOH for 5 min by submerging the slides in 
the solution. Glass slides were then baked at 60° C on a heat plate. Before the RNAscope® assay 
was performed slices were treated 10 min with peroxidase at RT by placing 2 drops of the 
peroxidase solution on the horizontally stored slices. Slices were then submerged in boiling 
target retrieval buffer for 3 min, washed in ultra-pure water, and treated with protease for 15 
min at 40° C in the HybeZ oven (Advanced cell diagnostics Inc., Newark, California, USA). 
Subsequently, slices were washed in ultra-pure water and approximately 40 µl of probe was 
applied to the slices and incubated for 2 hrs at 40° C in the HybeZ oven. Hybridization signals 
were amplified with the RNAscope® amplification kit, placing approximately 40 µl of each 
amplification buffer 1-6 on the slice and incubate them alternatingly 30 and 15 min at 40° C 
except for steps 5 and 6 which were performed at RT. Between each step slices were washed 
twice in wash buffer. Each slice was then incubated with 40 µl of detection solution for 10 min at 
RT and washed in water. After the RNA detection, slices were additionally immunolabeled for 
GFP protein. Immunofluorescence assay was performed as described above, however slices 
were kept mounted on glass slides and solutions were directly dropped on the slices.  
 
4.3.3 Fixed tissue imaging  
Immunofluorescence experiments as well as combined RNAscope® and immunofluorescence 
signals were imaged with a 10x objective of an epifluorescence microscope(Leica Microsystems, 
DM6000 for overview scans. High magnification images were taken with a confocal microscope 
(Leica Microsystems, SP8) using 63x objective (Leica Microsystems, #11506350) objectives. All 
fluorophores were imaged in sequential scans to avoid bleed-through. Fluorescent images were 
processed in Fiji (ImageJv1.51h, NIH, Bethesda, USA) and Adobe IllustratorC5 (Adobe systems, San 
Jose, USA).  
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4.4. Live imaging and electrophysiological recordings 
4.4.1 Live imaging of slice cultures with LFP measurement 
Hippocampal slice cultures were infected with two Ca2+ indicator expressing rAAVs 
simultaneously.  One expressed the green fluorescent Ca2+ indicator GCaMP6f under control of 
the astrocyte specific gfABC1D-promotor (further referred to as GFAP), while the second virus 
expressed the red fluorescent Ca2+ indicator jRGeco1a under control of the neuron-specific 
synapsin promotor.  After 3W incubation time slices were carefully cut out of the cultured 
membrane and placed in a submerged imaging chamber, perfused at 5 ml/min with oxygenized 
artificial cerebrospinal fluid (ACSF) (129 mM NaCl, 3 mM KCl, 1.25 mM NaH2PO4, 1.8 mM 
MgSO4, 1.6 mM CaCl2, 21 mM NaHCO3, and10 mM glucose, saturated with 95% O2, 5% CO2, pH 
7.3;) at 32° C.  [Ca2+]i transients of astrocytes and neurons were recorded simultaneously using 
an Olympus BX51WI microscope equipped with 20X objective and a CCD camera (ORCA-ER, 
Hamamatsu Photonics, Hamamatsu, Japan)  at 6.5 Hz and 13 ms exposure for each channel.  One 
recording session was 2500 frames in 6.5 min. At the same time LFPs with a field electrode 
placed in the CA3 region of the slice as described here Justus schneider 2015. In brief, the 
GB150F-8P borosilicate  glass electrodes (1–2 Mohm resistance) (Science Products GmbH, 
Hofheim, Germany) was back-filled with ACSF. With a mechanical micromanipulator (MM 33; 
Märzhäauser, Wetzlar, Germany) the electrode was positioned in pyramidal cell CA3 cell layer. 
Field potentials were amplified with EXT 10-2F amplifier (npi Electronic GmbH, Tamm, Germany). 
The signals were simultaneously low-pass filtered (3 kHz), and digitized with CED 1401 interface 
in the Spike2 software (Cambridge Electronic Design, Cambridge, United Kingdom). During the 
imaging sessions either carbachol (20 µM), carbachol+TTX (20 µM + 1 µM) or gabazine (5 µM) 
were washed in continuously, as indicated.  
4.5. Data analysis  
In case of the slice culture experiments image data was analysed using a version of the 
constrained non-negative matrix factorization (CNMF) algorithm described by Pnevmatikakis et 
al., 2016, modified by Lu et al., 2018 for compatibilty with MATLAB2018 (Mathworks Inc., Natick, 
Massachusetts, USA). Original scripts downloaded from GitHub repository: 
https://github.com/JinghaoLu/MIN1PIPE om 12.12.2018. 
The outputs are the relative intensities of each ROI over time. All following analysis was 
performed using custom made MATLAB2018 routines. Peaks were extracted for each trace using 
the build-in MATLAB command “findpeaks” specifying three criteria; firstly the peak height 
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(5xSTD+Mean), peak prominence(0.005 for astrocytic and 0.05 for neuronal ROIs), minimal 
distance between peaks. Only peaks fulfilling all three criteria were used for determining the 
peak frequency over time as well as the peak slope ratios. Electrophysiological data was 
analysed with custom made MATLAB2018 scripts applying fast fourier transformation (FFT filter, 
pass-band: 5–200 Hz) and subsequently processed with Welch’s algorithm as described in detail 
by Hollnagel et al., 2015. The power spectral density (PSD) was plotted and the time points of 
stable gamma oscillations were determined manually. 
Cross-correlation as well as the shuffling of data was completed with custom made MATLAB 
2018 routines. For the cross correlation the build-in command “xcorr” was applied with the 
limited lag and normalization parameters. The shuffling of data was achieved by sectioning each 
relative fluorescence trace of both astrocytic and neuronal traces into snippets of random size 
and randomizing the snippets’ order. This was repeated 1000 times for each astrocytic neuronal 
ROI pair with randomized snippet length.  
 
4.6 Chemicals 
 
Chemicals/Reagents Manufacturer 
2-Propanol Merck KGaA, Darmstadt, Germany 
Acetone Merck KGaA, Darmstadt, Germany 
Agarose Thermo Fisher Scientific Inc., Waltham, USA 
Ampicillin Merck KGaA, Darmstadt, Germany 
Aqua polymount Polyscience, Warrington,USA 
Atipamezol Prodivet Pharmaceuticals, Rearen, Belgium 
B27 Thermo Fisher Scientific Inc., Waltham, MA USA 
Bacto tryptone BD Bioscience advanced, USA 
Bacto Yeast Extract BD Bioscience advanced, USA 
Bovine Serum Albumin Merck KGaA, Darmstadt, Germany 
Calcium chloride Merck KGaA, Darmstadt, Germany 
Carprofen Norbrook, Newry, Ireland 
DAPI Serva Electrophoresis, Heidelberg 
DMEM Thermo Fisher Scientific Inc., Waltham, USA 
DPBS Thermo Fisher Scientific Inc., Waltham, USA 
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EBSS Thermo Fisher Scientific Inc., Waltham, USA 
Ethidium bromide Serva Electrophoresis, Heidelberg 
Ethylene glycol Merck, Darmstadt 
Fentanyl Janssen-Cilag GmbH, Neuss, Germany 
Fetal calf serum (FCS) Thermo Fisher Scientific Inc., Waltham, USA 
Flumazenil Fresenius Kabi Deutschland, Bad Homburg, Germany 
Glucose  Merck KGaA, Darmstadt, Germany 
Glycerol Carl Roth GmbH, Karlsruhe, Germany 
Glycine GERBU Biotechnik GmbH, Heidelberg, Germany 
HEPES GERBU Biotechnik GmbH, Heidelberg, Germany 
Horse serum Thermo Fisher Scientific Inc., Waltham, USA 
Hydrochloric acid  Merck KGaA, Darmstadt, Germany 
Hydrogen peroxide Merck KGaA, Darmstadt, Germany 
Isoflurane-Baxter Baxter, Unterschleiheim 
KCl Merck KGaA, Darmstadt, Germany 
Ketamine  CP Pharma, Burgdorf, Germany 
KH2PO4 Merck KGaA, Darmstadt, Germany 
Medetomidin Vetpharma animal Health, Barcelona, Spain 
MEM Thermo Fisher Scientific Inc., Waltham, USA 
MgCl2 Merck KGaA, Darmstadt, Germany 
MgSO4 Merck KGaA, Darmstadt, Germany 
Midazolam  Hameln pharma plus GmbH, Hameln, Germany 
NaCl Merck KGaA, Darmstadt, Germany 
NaH2HPO4 Merck KGaA, Darmstadt, Germany 
NaHCO3 Merck KGaA, Darmstadt, Germany 
Naloxon Inresa Arzneimittel GmbH, Freiburg, Germany 
NaOH Merck KGaA, Darmstadt, Germany 
Neurobasal (NB) medium Thermo Fisher Scientific Inc., Waltham, USA 
Normal goat serum Vector laboratories, Burlingame, USA 
Paraformaldehyde 37% Merck, Darmstadt 
Ringer solution  B. Braun, Melsungen 
Sucrose Carl Roth GmbH, Karlsruhe, Germany 
Tris Merck KGaA, Darmstadt, Germany 
TritonX-100 Merck KGaA, Darmstadt, Germany 
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Trypsin-EDTA Thermo Fisher Scientific Inc., Waltham, USA 
Xylocaine Astra Zeneca GmbH, Wedel, Germany 
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